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As one of the hottest research areas in organocatalysis, N-Heterocyclic Carbene (NHC) 
catalysis has been developed into a very powerful tool for asymmetric annulation reactions. 
This thesis describes my efforts during my PhD studies that focus on NHC catalysis to 
develop different sizes of ring compounds.  
Chapter 1 provides a detailed review of the recent development of NHC-catalyzed 
asymmetric annulations via azolium enolates and homoenolates.  
Chapter 2 presents an interesting work about NHC-catalyzed divergent annulation of enals 
with heterocyclic enones, affording either ε-lactones or spiro-heterocycles in good 
diastereoselectivity and enantioselectivity. 
Chapter 3 demonstrates highly efficient and diastereodivergent aza-Dies-Alder reactions 
using either NHC or chiral amine as the catalysts, accessing both diastereomers of a series of 
benzofuran-fused δ-lactams and dihydropyridines in nearly perfect enantioselectivity.  
Chapter 4 introduces the kinetic resolution of 1,1'-spirobiindane-7,7'-diol via enantioselective 
acylation. The spiro cyclic diol is a very useful structure, which can be employed as chiral 
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Chapter 1 Introduction 
1.1 Development of NHC in Organocatalysis 
During the past decades, Chemists began to recognize the importance of organocatalysis, 
which was previously overlooked, comparing to enzyme and metal complex catalysis. 
According to the function of the organocatalysts, that is withdrawing or donating electrons or 
protons from or to the reaction substrates or transition states, organocatalysis can be easily 
defined into four distinct areas: Bronsted acid and base catalysis and Lewis acid and base 
catalysis. Due to the catalysis concepts and modes were comprehended by chemists more and 
more clearly, great developments of these four areas have been reported since this century. 
1
 
As one of the hottest research area in organocatalysis, N-Heterocyclic Carbene (NHC) 
catalysis can date back to 1943, when Ugai reported the benzoin condensation reaction 
catalyzed by thiamine (vitamin B1).
2
 Later in 1966, Sheehan reported the asymmetric 
catalysis using chiral carbenes.
3
 Maybe due to the poor selectivity and efficiency, his report 
did not attract much attention. The first example of isolation and characterization of stable 
imidazolylidene carbene was repoted by Arduengo in 1991,
4
 although in carbene catalysis, 
carbenes are not isolated and usually produced in situ by the combination of a thiazolium, 
triazolium or imidazolium salt and a base in the reaction. All the above discoveries for 
carbenes gradually and finally opened the door to designing new NHC catalysts and reactions 
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1.1.1 Structure, and Synthesis of NHCs 
NHCs are defined as heterocyclic compounds containing a carbene carbon and at least one 
nitrogen atom. Within these criteria, various substitution groups and ring sizes can give many 
different carbene structures. However, the most commonly used structures of nucleophilic 
carbenes are shown in Figure 1-1. 
 
Figure 1-1. General structures of nucleophilic carbenes 
Although some carbene precursors can be isolated from nature sources, such as the thiamine 
(vitamin B1), most of them are designed and synthesized by chemists. And the synthesis of 
azoliums as carbene precusors has been recently reviewed in this paper.
5
 In enantioselective 
NHC-catalyzed transformations, the chiral triazolium salts (1.4 and 1.8), which were first 
synthesized by Knight and Leeper, are the most effective catalyst species in general (Scheme 
1-1).
6
 Their synthesis methods formed the basis for designing and synthesizing new chiral 
NHC structures, which were largely extended by Rovis, Enders, Bode, Scheidt, Glorius et al. 
later in different enantioselective reactions. And these catalyst structures have been recently 
summarized very detailed by Rovis in a review.
7
 
Scheme 1-1. Knight and Leeper’s chiral triazolium synthesis 




1.1.2 Benzoin Condensation 
Benzoin condensation is one of the most used reactions in C-C bond formation. It was first 
reported in 1832, under the catalysis of cyanide anions, aldehydes could dimerize to give 
α-hydroxyketones (benzoins).8 And in 1943, Ugai reported the first NHC catalyzed benzoin 
condensation reaction by using thiamine (vitamin B1).
2
 In 1958, Breslow made an elegant 
mechanistic proposal for this transformation, establishing the most understood mechanism 
and intermediates 1.10 for most NHC-catalyzed reactions (Scheme 1-2).
9
  
Comparing to cyanide anions, NHC catalysts have lower toxicity and have the opportunity to 
control the stereoselectivities in the reaction by designing different chiral NHCs. Since 
Sheehan’s first efforts in enantionselective benzoin condensation,3,10 a wide variety of NHC 
structures have been developed by different groups for this reaction, resulting in constant 
improvements in reactivity and selectivity (Scheme 1-3).
11
 As a result, benzoin condensation 
has been a benchmark reaction to test effectiveness of new designed NHC structures. 
Scheme 1-2. Mechanism of benzoin condensations as proposed by Breslow in 1958 
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Scheme 1-3. Selected catalysts for NHC-catalyzed asymmetric Benzoin reactions 
 
 
1.1.3 Stetter Reaction 
Stetter first reported the reaction between Breslow intermediate and Michael acceptors other 
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than aldehydes in 1970’s, which could afford the valuable 1,4-dicarbonyl compounds.12 A 
broad range of Michael acceptors have been reported since, such as α,β-unsaturated ketones, 
esters, nitriles, sulfones and so on. Based on some previous results,
13
 first general 
enantioselective intermolecular Stetter reaction was achieved by Enders group in 2008. 
Enders and co-workers reported the addition of aryl aldehydes 1.12 to chalcones 1.13, in 
good yields with promising enantionselectivity (up to 78% ee).
14
 Nearly at the same time, 
Rovis group described the Stetter reaction between glyoxamides 1.16 and alkylidene 
malonates 1.17 in good yield and enantionselectivity (up to 90% ee) ( Scheme 1-4).
15
 
Scheme 1-4. Enantioselective intermolecular Stetter reaction 
 
1.1.4 Conjugated Umpolung 
When α, β-unsaturated aldehydes are used in NHC catalyzed reactions, the intermediate in 
these reactions will be different from the one using saturated aldehydes, because there is a 
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conjugation system in the Breslow intermediate, which will allow the nucleophilicity to 
transfer to the β-position, which is called the homoenolate (Scheme 1-5). 
Scheme 1-5. Reactive intermediates generated from α, β-unsaturated aldehydes 
 
The reactive homoenolate equivalents generated from NHC catalyzing the α,β-unsaturated 




Both described the same selective annulation of enals with aromatic aldehydes and 
α-trifloromethylketones affords the γ-butyrolactones 1.23. The mechanism is shown by the 
catalytic cycle shown below. NHC attacking the α,β-unsaturated aldehydes affords the 
Breslow intermediates 1.24, which will go through proton transfer to give the homoenolates 
1.25. Actually, the strength and amount of base used in these reactions and the structure of 
NHC catalysts are all crucial to the formation of homoenolates. After the addition of the 
homoenlolate to the aldehyde, there will be esterification of the activated carboxylate 1.26 to 
regenerate the NHC catalysts to close the catalytic cycle (Scheme 1-7). 
Scheme 1-6. Formation of γ-butyrolactones by NHC-catalyzed conjugate umpolung of 
enals 
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Scheme 1-7. NHC-promoted γ-lactone forming annulations via catalytically generated 
homoenolate equivalents 
 
1.2 NHC-Catalyzed Cyclizations via Azolium Enolates  
Usually, the azolium enolates are formed by the combination of NHC and α-functionalized 
aldehydes, or enals, or ketenes, or saturated aldehydes under stoichiometric oxidation or 
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activated esters. Azolium enolates reacting with different electrophiles can lead to a series of 
NHC catalyzed cycloadditions, such as [2+2], [2+3], [2+4] and so on (Scheme 1-8).  
Scheme 1-8. NHC-mediated generation of azolium enolates 
 
 
1.2.1 [2+2] Cycloaddition 
In 2008, Ye group reported a Staudinger reaction between ketenes and N-Boc imines by using 
the L-pyroglutamate-derived NHC 1.30，giving corresponding cis-β-lactams 1.29 in good 
yields with good diastereo- and enantioselectivities (up to 99% ee) (Scheme 1-9).
17
  
Scheme 1-9. NHC-catalyzed Staudinger reaction of ketenes with aldimines by Ye group 
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Concurrently, Smith and Co-workers utilized the diphenylketene with N-tosyl imines 1.32 
under the aminoindanol-derived precatalyst 1.34 and another rarely used imidazolium 
precatalyst 1.35, for [2+2] cycloaddition.
18
 Different N-tosyl imines were tested in this 
reaction, providing the β-lactam products 1.33 in moderate enantioselectivity (up to 75% ee) 
(Scheme 1-10). 
The reaction mechanism involves the NHC attacking the ketene, leading to the formation of 
NHC-bound azolium enolate intermediate 1.36. Then the azolium enolate undergoes [2+2] 
cycloaddition with the imine 1.32, forming the intermediate 1.37, which affords the β-lactam 
1.33, with the release of NHC catalyst (Scheme 1-11).  
 
Scheme 1-10. NHC-catalyzed [2+2] by Smith group 
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Later, Ye group presented similar reactions by replacing the imine with other electrophiles, 
such as 2-oxo-aldehydes 1.31 and trifluoromethylketones 1.41 (Scheme 1-12).
19
 
For the synthesis of β-lactone, it was found that substituents of the ketenes had great 
influence on the enantioselectivity of the β-lactones. In the first example, the use of 
alkylarylketenes bearing either a 2-substituent on the aryl unit, or an isopropyl alkyl group 
gave good yield and very high enantioselectivity. However, in the second reaction, these 
substrates gave no reaction. 
Scheme 1-12. [2+2]-Cyclizations of ketenes with 2-oxo-aldehydes and 
trifluoromethylketones by Ye group 
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Diazenedicarboxylates 1.44 can also be used in the cycloaddition reaction with ketenes via 
NHC catalysis (Scheme 1-13).
20
 Ye and co-workers found that the N-subsituent (carboxylate 
vs benzoyl) of diazenes had important influence on the modes of cycloadditions. The reaction 
of ketenes and diazenedicarboxylates, gave the [2+2] cycloaddition product, whereas the 
reaction of ketenes and N-benzoyldiazenes, gave the [4+2] cycloaddition product. 
Interestingly, alkenes with bulky groups such as 2-chlorophenylethylketene, or i-Pr not only 
led to products with reduced ee value but also resulted in a change of product configuration. 
Scheme 1-13. [2+2]-Cyclizations of ketenes with diazenedicarboxylates with hetero atom 
electrophiles by Ye group 
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In 2010，Ye and co-workers reported the cycloaddition between ketenes and isatins 1.47 via 
NHC catalysis, giving the synthetic useful and bioactive spirocyclic oxindole-β-lactones 1.48 
with moderate diastereoselectivities (typically 3:1, anti/syn) and excellent enantioselectivities 
(up to 99% ee).
21
 However, Ketenes with aryl group of 2-chlorophenyl, 2-naphthyl did not 
work or only gave very low yield, due to steric hindrance. Besides, ketenes with longer or 
branched alkyl chains also gave decreased yields. Chemical transformation via ring opening 
with Grignard reagents or decarboxylation of the spirocyclic oxindole-β-lactones gave the 
corresponding 3-hydroxy- or 3-alkylenyloxindoles in very good yields.In a related research, 
they developed the Staudinger reaction of ketenes with isatin-derived ketimines 1.50 via 
bifunctional NHC 1.52, which constructed spirocyclic oxindolo-β-lactams 1.51 in high yields 
with excellent dr and ee (Scheme 1-14).
22
 
Nitrosocompounds 1.54 can also serve as the cycloaddition reaction partners with the ketenes 
(Scheme 1-15).
23
 Ketenes with aryl group of 2-chlorophenyl and 1-Naphthyl worked well in 
this reaction, but the phenylmethylketenes gave the poorest ee and yield. α-Hydroxy amides 
1.56 can be easily prepared from the 1,2-oxazetidin-3-ones 1.55 via zinc-mediated reductive 
cleavage without erosion of ee. 
Scheme 1-14. [2+2] Annulations of ketenes with isatins and isatin-derived ketimines by 
Ye group 




 Scheme 1-15. [2+2]-Annulations of ketenes with nitrosocompounds by Ye group 
 
Ye group also used the N-Sulfinylanilines 1.58 as the coupling partner with the ketenes 
(Scheme 1-16).
24
 Interestingly, both enantiomers in very good yields (typically 73-96%) with 
excellent enantionselectivities (typically 80-99%) can be obtained by using different 
structures of NHC precatalysts. 4 Å molecular sieves (MS) were very crucial for the high 
catalyst efficiency (only 1 mol% catalyst loading). Key structures of bioactive compounds 
and synthetic useful catalysts can be accessed from easy chemical transformation of the 
cyclization products. 
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Scheme 1-16. [2+2]-Annulations of ketenes with N-Sulfinylanilines by Ye group 
 
Enantioselective dimerization of disubstituted ketenes has also been realized under the 
precatalyst, derived from L-pyrogutamic acid (Scheme 1-17).
25
 It was found a chiral NHC 
1.63 with a proximal free hydroxyl group giving better results than the corresponding NHC 
with its hydroxyl group protected. A possible explanation is that there is an H-bonding 
between NHC and ketene. Except the ethyl(2-chlorophenyl)ketene, the other ketenes gave 
good yield with up to 97% ee. Besides, ketenes generated in one pot reaction also worked for 
this dimerization reaction (Scheme 1-18). 
Scheme 1-17. Asymmetric dimerization of disubstituted ketenes 
 
 
Scheme 1-18. One-pot ketene generation and dimerization 
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In 2011, another interesting reaction was reported by Ye group (Scheme 1-19).
26
 They 
demonstrated that, ketenes reacted with isothiocyanates 1.67 at room temperature, giving the 
[2+2] cycloaddition products 1.68 as the major product, while reacted with N-benzoyl 
isothiocyanates at -40 
o
C, affording the [2+2+2] cycloaddition products 1.69 as the major 
products. A variety of aryl(alkyl)ketenes were tested in both reactions, giving good yields 
(62–85%) with excellent enantioselectivities (92-97% ee) for the [2+2], and equally good 
yields (50–72%) but with reduced enantioselectivities (61–86% ee) for the [2+2+2]. Similar 
to previous reports of NHC-catalyzed cycloadditions, ketene with an o-chlorophenyl group or 
isopropyl group gave no cycloadducts. 
Scheme 1-19. NHC-catalyzed enantioselective [2 + 2] and [2 + 2 + 2] cycloadditions of 
ketenes with isothiocyanates 
 
The proposed mechanism is shown below (Scheme 1-20). NHC attacking the ketenes forms 
the intermdediate 1.70, which goes through the addition to isothiocyanate to generate 
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intermediate 1.71. If intermediate 1.71 continues with N-addition to the acyl azolium and 
regenerates the NHC, it will give [2+2] cycloaddtion. However, when the intermediate 1.71 
contains N-benzoyl structure, it is stabilized with resonant structure 1.72, which favors the 
S-addition to another molecule of kentene to generate the intermediate 1.73 at low 
temperature. Intermediate 1.73 goes through O-addition to the acyl azolium, giving the 
[2+2+2] cycloaddition and regenerating NHC. 
Scheme 1-20. Plausible reaction pathways 
 
In addition to ketenes, enals were alternative precursors to generate azolium enolates for [2+2] 
cyclizations (Scheme 1-21). Very recently, Scheidt and co-workers demonstrated the 
experimental and computational study of the kinetic resolution of racemic 
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α-substituted-β-ketoesters 1.74 for the synthesis of bicyclic β-lactones 1.77.27 




1.2.2 [2+3] Cycloaddition 
To proceed the [2+3] cyclization, the 3C-building block reacting with azolium enolates must 
contain nucleophilic and electrophilic motifs at the 1 and 3 position of its building block. 
Acctually, there are only several reports about the [2+3] cyclolization. 
A route to biologically importantnt oxazolin-4-ones via the formal [2+3] cycloaddition 
between alkylarylketenes and oxaziridines has been reported by Ye and co-workers in 2010 
(Scheme 1-22).
28
 This method gave good to moderate yields (52−78%) and high diastereo 
and enantioselectivity (up to 16:1 dr and 95% ee) for a range of alkylarylketenes. As with 
previous reports of NHC-catalysed formal cycloadditions, trace amount of product was 
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obtained when either 2-chlorophenylethylketene or 1-naphthylethylketene was used. It’s very 
interesting that, two opposite enantiomers can be obtained by using different NHC 
precatalysts with identical absolute configurations. Besides, the kinetic resolution of racemic 
oxaziridine 1.80 was also reported in this NHC catalyzed [2+3] reaction. (-)-1.80 and 
(+)-1.80 was recovered in 15–26% yield with 76–99% ee and  28–36% yield with 10–67% 
ee, respectively.  
Scheme 1-22. Formal [2+3] cycloaddition of ketenes and oxaziridine by Ye group 
 
Mechanistically, the reaction is believed to be initiated by the addition of NHC to the ketene, 
generating the azolium enolate. The subsequent oxidation of the enolate with the oxaziridine 
affords the intermediate 1.83 as well as the imine. Then the intermediate attacks the imine 
forming a zwitterionic complex 1.84, which goes through N-addition to the acyl azolium, 
giving the [2+3] cycloaddition and regenerating NHC (Scheme 1-23). 
Another [2+3] annulation reaction was reported by Enders group between α-chloroaldehydes 
and nitrovinylindoles 1.87 (Scheme 1-24).
29
 They also tested aldehydes with some other 
leaving group in α-position to the aldehyde carbonyl group. Although, different 
α-functionalized aldehydes had some influence on the selectivity, all gave excellent 
diastereoselectivities (> 20:1), and ee values (94–99% ee). For reactivity, 1.89 and 1.90 
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furnished the product with same good yield in time of just 2 h, while aldehydes 1.91–1.93 
gave moderate yields (44–61% yield) even after a prolonged reaction time of up to 24 h. 
Besides, a variety of indole substrates bearing either electron-withdrawing or 
electron-donating groups gave excellent diastereo- (> 20:1) and enantioselectivities (96–99% 
ee), and moderate to good yield (30%-75%). 
Scheme 1-23. Possible catalytic cycle 
 
Scheme 1-24. Influence of the functional group of aldehyde on yield and diastereo- and 
enantioselectivity 
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Because of the biological importance of the pyrrolo[1,2-a]indole 1.88 scaffold, several 
chemical transformation was conducted (Scheme 1-25). For example, the nitro group was 
easily reduced to a primary amine and protected by Boc group, without erosion of the 
enantioselectivity. Remarkably, the reduction of the nitro group and a subsequent Pictet–
Spengler reaction afforded the tetracyclic pyrrolo[1,2-a]indole skeleton 1.95, which was 
tested as psychotropic drugs and for treatment of cardiovascular and renal disorders. 
Scheme 1-25. Derivatization of 1.88; bottom: examples of psycho-tropic compounds 
with this scaffold 
 
Regarding the mechanism of this reaction, NHC attacks the α-chloro aldehyde forming the 
chlorinated Breslow intermediate 1.96. NHC-bound azolium enolate 1.98 generated from the 
elimination of chloride undergoes Michael addition to 2-nitrovinylindole 1.87. Subsequent 
intramolecular lactamization of intermediate 1.99 furnishes the desired 
1H-pyrroloindol-3(2H)-one 1.88 and regenerates the carbene catalyst (Scheme 1-26). 
Scheme 1-26. Proposed mechanism of reaction between azolium enolates and 
2-nitrovinylindoles 
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Recently, Glorius reported two different reaction pathways for enals and 
N-iminoisoquinolinium ylides 1.101, affording either NHC-catalyzed homoenolates to 
generate pyridazino[6,1-a]isoquinolines 1.102 or NHC-catalyzed azolium enolates to 
generate pyrazolo[5,1-a]isoquinolines 1.103 (Scheme 1-27).
30
 It has been proved that both 
the selection of the NHC precursors and reaction conditions could have a very important 
impact on the reaction pathways, leading to different regioselectivities of the same starting 
materials. 
Scheme 1-27. Two pathways for the annulation reaction of enal with 
N-iminoisoquinolinium ylides 




1.2.3 [2+4] Cycloaddition 
In 2006, Bode group reported the first highly enantioselective azadiene Diels-Alder reactions 
catalyzed by chiral NHC (Scheme 1-28).
31
 Cinnamaldehyde-derived imines 1.104 including 
electron-rich and electron-deficient derivatives, along with heterocyclic and aliphatic 
examples processed this reaction smoothly in moderate to good yileds (55-90%) with nearly 
perfect enantionselectivity (99% ee). Besides, variation of the enal substrates with either ester 
or ketone groups, gave moderate to good yileds (51-71%) with excellent enantionselectivity 
(97-99% ee). 
Scheme 1-28. NHC-catalyzed aza-Diels–Alder reactions by Bode group 
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Mehcanistically, under the above condition, the reaction processed via the azolium enolate 
rather than homoenolate, which was a competitive intermediate and the bulky (Z)-enolate 
reacting as the dienophile would lead to the cis-stereoselectivity (Figure 1-2).  
 
Figure 1-2. Stereochemical model for endo-Diels-Alder cycloaddition 
In the same year, the same group also demonstrated that α-chloroaldehydes as alternative 
substrates could be used for the same type reaction via the catalytic generation of a chiral 
enolates with very low catalyst loading (0.5-2 mol%), giving the lactone products in good 
yields (70-95%) with excellent enantioselectivities (86−99% ee) (Scheme 1-29).32 
Scheme 1-29. Chiral NHC catalyzed enantioselective oxodiene Diels-Alder reactions 
with low catalyst loadings 
 
Using the commercially available α-chloroaldehyde bisulfite salts 1.111 instead of 
α-chloroaldehyde also provided the same azolium enolate intermediate (Scheme 1-30).33 This 
method could also be applied to a wide range of substrates including not only the previously 
reported process, but also the unsubstituted bisulfite adduct, affording the hetero-Diels–Alder 
products in similarly good yields (52-98%) and excellent enantioselectivity (up to >99% ee). 
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Besides, the biphasic reaction condition demonstrates this kind of catalysts is water-tolerant.  
Scheme 1-30. Chiral NHC-Catalyzed oxodiene Diels-Alder reactions with 
α-chloroaldehyde bisulﬁte salts 
 
Very recently, Enders and co-workers employed cyclic 1-azadiene 1.115 as reaction partner 
with α-chloroaldehydes for [2+4] cycloadditions (Scheme 1-31).34 
Scheme 1-31. Asymmetric NHC catalyzed annulation of 2-alkenylbenzothiazoles with 
α-chloro aldehydes 
 
Nearly at the same time, the same research group also reported another interesting substrate 
for NHC catalyzed cycloaddition (Scheme 1-32).
35
 N-(benzothiazolyl)imines 1.117 in 
combination with an azolium enolate 1.118 generated from NHC addition to 
α-chloroaldehyde could not only give the well-established β-lactam 1.120 , but also provide 
access to the [4+2] annulation product 1.119.  
Scheme 1-32. Reactions of N-(benzothiazolyl)imines with NHC-bound enolate 
intermediates 
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After the optimization of the reaction conditions, a wide range of 2-benzothiazolimines with 
varied α-chloroaldehydes as reaction partners, produced the desired 
benzothiazolopyrimidinones in moderate to good yields (34-78%) with excellent regio and 
stereoselectivities (4:1- >20:1 dr, 87-99% ee). 
In order to overcome some of the drawbacks during the treatment of functionalized aldehydes, 
ketenes, or esters, Rovis group developed an alternative method to generating the azolium 
enolate via simple aliphatic aldehydes for the highly enantioselective synthesis of lactones 
and lactams under oxidative conditions (Scheme 1-33).
36
 
Scheme 1-33. NHC catalyzed asymmetric oxidative hetero Diels–Alder reactions with 
simple aliphatic aldehydes 
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In 2010, Bode and co-workers first employed α,β-unsaturated aldehydes in the direct 
generation of azolium enolates rather than the commonly formed homoenolates (Scheme 
1-34).
37
 They found the key to the successful formation of enolate was the strength of the 
base used for free NHC generation in this reaction. They could get enolate quivalent pathway 
products as major products by the use of DMAP and NMM, while the use of stronger base, 
such as DBU, would give the homoenolate pathway products to a large extent. A wide range 
of electron-deficient enones worked very well with the catalytically formed enolate 
equivalent, giving perfect diastereo- and enantioselectivity (typically >20:1 dr and 99% ee) in 
the formation of Diels–Alder products. 
Later, Chi group found that the use of chalcones with an electron-withdrawing group (EWG) 
at the α-position (alkylidene diketones) as the substrates also alternated the reaction pathway 
of NHC-catalyzed α,β-unsaturated aldehydes (Scheme 1-35).38 Different β-aryl enals 
proceeded with exceptionally high diastereo- and enantioselectivies (typically >20:1 dr and 
99% ee), while enals with β-alkyl substituents could only provide access to Stetter type 
product under the same NHC catalyst. Finally, they partially solve this problem by going 
back to modify this reaction with the achiral catalyst, affording dihydropyran-2-ones in 
moderate diastereoselectivity (3:1 to 5:1 dr). 
Scheme 1-34. Chiral NHC catalyzed generation of ester enolate equivalents from 
α,β-unsaturated aldehydes for enantioselective Diels–Alder reactions 
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Scheme 1-35. Hetero-Diels–Alder reaction with α-modified chalcones  
 
Besides of [2+2] cycloaddition, azolium enolate generated from addition of NHC to ketenes 
could also be employed for [2+4] cycloaddition. In 2008, Ye and co-workers reported the 
chiral NHCs-catalyzed formal [2+4] cycloaddition between ketenes and enones, giving 
biological important δ-lactones 1.140 in moderate-to-good yields (61−93%) and high 
diastereoselectivity (15:1 to 99:1 dr) and enantioselectivity (84−92% ee) (Scheme 1-36).39 
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Scheme 1-36. [4 + 2] Annulation of ketenes with enones 
 
Ketenes generated in one pot reaction from corresponding acyl chloride under excess NEt3 
also worked well for this reaction of cycloaddition reaction. 
As I have rendered in [2+2] cycloaddition, benzoyldiazenes would favor [2+4] cycloaddition 
in the reaction with azolium enolates, serving as the electrophiles like enones (Scheme 
1-37).
40
 A wide range of alkylarylketenes reacted well, giving [2+4] products in good yield 
and excellent enantioselectivity (up to 97% yield and 97% ee). Similar to previous example, 
two opposite enantiomers can be obtained by using the NHC precatalyst 1.30 and 1.144, with 
identical absolute configurations. 
Scheme 1-37. NHC-catalyzed [2+4] cyclization with ketenes  
 
The different enantioselectivities observed may result from the two proposed transition states 
based on the structure difference between the two NHC catalysts (Figure 1-3). In transition 
state A (TS A), the N-phenyl group of NHC, the triazole, and the enloate are coplanar. 
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However, in transition state B (TS B), both the N-mesityl group and the enolate are 
perpendicular to the triazole, due to steric hindrance. Thus, the opposite enantioselectivity is 
favored. 
  
Figure 1-3. Possible transition states 
In 2011, Chi and colleagues employed the formylcyclopropanes 1.145 as the hetero-Diels 
Alder reaction partners with the chalocnes 1.146 (Scheme 1-38).
41
 This was the first example 
using formylcyclopropanes as enolate precursors. The reaction was tolerated by a wide range 
of substrates, giving all the products in good yield (typically >90%) and with nearly perfect 
enantioselectivity (typically >99% ee) and excellent diastereoselectivity (typically >10:1 dr). 
Scheme 1-38. Formal Diels-Alder reactions of chalcones and formylcyclopropanes 
catalyzed by chiral NHC 
 
Later, the same research group reported the activated arylacetic acid ary ester 1.148 served as 
the enolate precursor, reacting with the α,β-unsaturated imines 1.149 (Scheme 1-39).42 This 
method provides alternatives to overcome some drawbacks of using enals or α-functionalized 
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aldehydes and give the lactam products 1.151 in moderate to good yield (51-94%) with 
moderate to good diastereo- and enantioselectivity (60-92% ee, 6:1 to >20:1 dr). 
Scheme 1-39. Enantioselective activation of stable carboxylate esters as enolate 
equivalents via NHC catalysts 
 
Later in 2013, Chi group expanded the ester substrate scope to simple alkylacetic esters and 
their derivatives, providing 20 examples with uo to >20:1 dr and >99% ee (Scheme 1-40).
43
 
Scheme 1-40. Organocatalytic activation of alkylacetic esters as enolate precursors to 
react with α,β-unsaturated imines 
 
Direct α-functionalization of simple aldehydes via oxidation NHC catalysis for [2+4] 
cycloaddition was also disclosed by Chi group in 2012 (Scheme 1-41).
44
 The reaction process 
goes through the oxidation of Breslow intermediate, followed by selective deprotonation. 
Scheme 1-41. Direct α-functionalization of aldehyde 
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Recently, Scheidt and colleagues reported the synthesis of dihydrocoumarins 1.160 via an in 
situ activated NHC catalysis (Scheme 1-42).
45
 Both of the reaction partners were generated in 
situ simultaneously, affording the NHC-enolate intermediate for the [4+2] process. 
Scheme 1-42. Scheidt’s [2+4] cyclization with carboxylic acids 
 
 
1.3 NHC-Catalyzed Cyclizations via Homoenolates 
NHC catalyzed generation of homoenolates was first introduced by Bode and Glorius 
group,
16
 opening an entirely new research area and catalytic mode of C-C bond formation. 
They found that the α, β-unsaturated aldehydes can exhibit nucleophilic character at the β 
position to the carbonyl group under the NHC catalysis. Since then, a wide range of 
NHC-catalyzed cyclizations via homoenolates with carbonyl and some other electrophiles 
have been reported, not only started from α,β-unsaturated aldehydes, but also some other new 
precursors. 
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1.3.1 Reaction of Homoenolates with Carbonyl Electrophiles and 
Imines 
In 2010, Scheidt and co-workers tried a different way to access optically active 
γ-butyrolactones, using chiral titanium alkoxides as Lewis acids with racemic NHC catalysis 
(Scheme 1-43).
46
 With (R,R)-Ti-TADDOL 1.164 as the Lewis acid and 15 mol % NHC 1.22 
at -20
o
C, only the cis diastereoisomer was generated with 60% yield and 60% ee. It was 
believed that the enantiomeric excess of the lactone product originated from the influence of 
the chiral Lewis acid, which was involved in the key bond formation.  
Scheme 1-43.Ti−Taddol/NHC cooperative catalysis 
 
Scheidt group subsequently demonstrated the NHC-catalyzed enals with α- ketophosphonates 
for the synthesis of γ-butyrolactones (Scheme 1-44).47 This reaction was rather challenging 
because of the steric environment around the target carbonyl group. Interestingly, the high 
level of selectivity was achieved by the choice of chiral NHCs through computational 
modeling. When catalyst 1.168 and MTBD (7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene) 
were employed, the pharmaceutical useful products 1.167 were produced in moderate to good 
yields (54−93%) and enantioselectivity (78−91% ee), and moderate diastereoselectivity (up 
to 3:1 dr). 
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Scheme 1-44.NHC-catalyzed enals with α- ketophosphonates 
 
In 2006, Nair and co-workers reported the synthesis of highly functionalized spiro 
butyrolactones via NHC-catalyzed homoenolate chemistry (Scheme 1-45).
48
 Simple ketones 
actually cannot work well as the electrophile with homoenolates, however, in this method, 
1,2-diones proceeded smoothly with either electron-rich or electron-deﬁcient enals, giving the 
spirocyclohexanone products 1.173 in good yiled ( 60-74%), and spirooxindole γ-lactones 
1.172 in excellent  yield(85−98%) with rather low diastereoselectivity (1:1).  
Scheme 1-45. Synthesis of spirocyclic-γ-lactones 
 
This type of reaction was later investigated to improve the the diastereo- and enantiocontrol, 
which was believed as a challenge for a period of time. Ye and co-worker employed a chiral 
NHC 1.177 bearing a proximal hydroxyl group derived from L-pyroglutamic acid for the 
annulation of enals with isatins 1.175 (Scheme 1-46).
49
 The hydroxyl group was very crucial 
to the effectiveness of NHC to give the spirocyclic oxindolo-γ-butyrolactones 1.176 in good 
yields (typically >85%) with improved diastereo- and enantioselectivities 
PHD DISSERTATION 2016                                                                   WANG MIN 
34 
(typically >85%ee, >15:1 dr). 
Scheme 1-46. Enantioselective annulation of enals with isatins 
 
In Schedidt’s group, they tried to add the alkali salt to the reaction as the co-catalyst with 
NHC, in order to enhance the enantioselectivity of the resultant spirooxindole products 
(Scheme 1-47).
50
 A wide range of cinnamaldehyde derivatives reacted with isatins, affording 
desired products 1.180 in 70−93% yield, 1.6:1 to 20:1 dr, and 86−99% ee. While aliphatic 
enal (trans-butenal) was employed in the reaction, extensive screen of reaction conditions 
were needed to get satisfying results.  
Scheme 1-47. An NHC/lewis acid strategy for the stereoselective synthesis of 
spirooxindole lactones 
 
Most notably, this cooperative carbene catalysis provided access to the enantioselective total 
synthesis of maremycin B in five steps from lactone without using protecting groups and in 
17% overall yield (Scheme 1-48). 
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Scheme 1-48. Total synthesis of maremycin B 
 
In addition to lactones, Bode and co-workers first presented the annulation of enals to imines 
for γ-Lactams via homoenolates in 2005 (Scheme 1-49).51 In this reaction, they found that 
N-4-methoxybenzenesulfonyl imines 1.183 could serve as the ideal reaction partner with a 
variety of functionalized α,β-unsaturated aldehydes, because N-4-methoxybenzenesulfonyl 
imines could reduce the direct addition of NHC to imines and react faster with enals than 
enals themselves. 
Scheme 1-49. Catalytic synthesis of γ-lactams via direct annulations of enals and 
N-sulfonylimines 
 
Later in 2008, the same research group expanded the imines to chemically stable, yet highly 
reactive, ketimines 1.186 derived from saccharin (Scheme 1-50).
52
 Most notably, this 
annulation reaction was very effective and only required 0.5 mol % catalyst loading for a 
broad range of enal and cyclic sulfonylimines, giving up to 98% yield. They provided a 
possible explanation for the effectiveness of this NHC catalysis. The reaction proceeded via 
PHD DISSERTATION 2016                                                                   WANG MIN 
36 
an ene-like addition process guided by the hydrogen bond between intermediates rather than 
the common homoenolate pathway (Figure 1-4). 
Scheme 1-50. Scope of the cyclic sulfonylketimine 
 
 
Figure 1-4. Ene-like transition state of cyclic sulfonylketimine 
The group also tried the reaction with chiral NHCs, affording the product in excellent yield 
(91%), with encouraging diastereo- and enantioselectivities (73% ee and 6:1 dr). 
Scheidt and colleagues disclosed a cooperative catalytic system combining NHC and Lewis 
acid together, providing access to highly substituted γ-lactams via the addition of 
homoenolate to hydrazones 1.191 (Scheme 1-51).
53
 It was proposed that the Lewis acidic 
magnesium (II) salts would coordinate to the oxygen and nitrogen in the substrates, activating 
the acyl hydrazone toward nucleophilic addition by homoenolates. The effective cooperative 
catalysis with different enals delivered γ-lactam products in 61−85% yield, 85−97% ee, and 
5:1 up to >20:1 dr. 
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Scheme 1-51. Addition of homoenolate to hydrazones via NHC catalysis 
 
Brønsted acids were also employed in cooperative catalysis with NHC by Rovis group 
(Scheme 1-52).
54
 In order to explain the role of the acids in their reaction system, they tried 
the reaction with an achiral carbene, but chiral, and enantioenriched amino acids, and got 
products with enantiomer excess. This was believed to give evidence for hydrogen bonding 
existing in the transformation. It is proposed that the weak base 1.197 deprotonates NHC 
precursors to form the free carbene, which then adds to the enal, forming homoenolates. The 
conjugate acid of the base would bond with aza-diene through hydrogen bonding, making it 
more electrophilic (Figure 1-5). 
Glorius and co-workers later disclosed a dual catalysis system for the annulation of sterically 
hindered homoenolate with isatins, also via the intergration of NHC and Brønsted acid 
(Scheme 1-53).
55
 The acid co-catalyst was crucial for the reactivity and diastereo- and 
enantioselectivity of the reaction. 
Scheme 1-52. NHC/ Brønsted acids cooperative catalysis 





Figure 1-5. Proposed pathway for trans-γ-lactam formation 
 




1.3.2 Reaction of Homoenolates with 1,3-Dipoles 
In 2007, Scheidt group first reported the [3 + 3] cycloaddition between azomethine ylides 
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1.204 and NHC-generated homoenolate (Scheme 1-54).
56
 α, β-unsaturated aldehyde with 
electron-donating groups on the aryl ring could afford the desired product in good yield (up 
to 94%), but electron withdrawing groups on the aryl ring did not yield products. β-alkyl 
substituents and extended dienylic enals could also be tolerated in this reaction to afford 
products in moderate yields. Besides, various substituted aryl groups on the azomethine imine 
were also suitable partner, while enolizable or 2-substituted aryl substituents gave no 
products. Remarkably, the high level of syn diastereoselectivity for the products was 
proposed due to hydrogen bonding assembly between the imine and the Breslow intermediate 
(Figure 1-6). 





Figure 1-6. Hydrogen bonding in the intermediate 
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In a related research, the same group disclosed nitrones 1.207 were also good coupling 
partners with homoenolates for [3 + 3] annulation (Scheme 1-55).
57
 Upon the addition of 
MeOH, the alcoholysis of the annulation products could easily occur to generate the γ-amino 
esters 1.210. 
Scheme 1-55. Cycloaddition between nitrones and NHC-generated homoenolate 
  
 
1.3.3 Reaction of Homoenolates with Michael Acceptors 
In addition to annulation with carbonyls, imines, 1,3-dipoles, the NHC-generated 
homoenolate has also been utilized in the reaction with Michael acceptors. 
In 2006, Nair and colleagues reported an unexpected ﬁve-membered carbocycles formation 
via the reaction of chalcones and NHC-generated homoenolates (Scheme 1-56).
58
 
Mechanistically, the reaction begins with the formation of homoenolates as usual, followed 
by the Michael addition of the homoenolate to the chalcone, giving intermediate 1.217. The 
ketone generated from the tautomerization of 1.217 would undergo an aldol reaction, 
providing the acyl azolium intermediate. The following cyclization and decarboxylation 
furnishes the final observed cyclopentene compounds 1.220 (Scheme 1-57). 
 
PHD DISSERTATION 2016                                                                   WANG MIN 
41 
Scheme 1-56. Reaction of chalcones and NHC-generated homoenolates 
 
Scheme 1-57. Proposed mechanism 
 
The same research group continued to explore the reactivity of homoenolates towards 
cross-conjugated dienones (Scheme 1-58).
59
 Interestingly, they got not only the previous 
cyclopentene type products 1.229 but also cyclopentanone products 1.226. It was believed 
that the product selectivity arose from either intramolecular aldol/decarboxylation pathway or 
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C-acylation of the acylazolium pathway. In general, different substrates gave different ratios 
of these two kinds of products. Remarkably, a number of dibenzylidene cyclopentanones 
employed in this reaction only generated spirocyclopentanone derivatives (Scheme 1-59). 
Scheme 1-58. Reactions between homoenolates and cross-conjugated dienones 
 
Scheme 1-59. Reactions between homoenolates and dibenzylidene cyclopentanones 
 
Shortly after Nair’s report about the homoenolates towards racemic trans-cyclopentenes, 




A different reaction mechanism was proposed by Bode’s group (Scheme 1-61). The reaction 
started from cross-benzoin reaction, followed by an NHC-promoted oxy-Cope 
rearrangement. 
Scheme 1-60. Enantioselective cis-cyclopentene-forming annulation 
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Scheme 1-61. Mechanism proposed by Bode’s group 
 
In a related research, Scheidt and co-workers employed a cooperative catalytic system by 
combining NHC and Lewis acid for the same starting materials as Nair’s work, but only got 
cis-cyclopentene isomer (> 20:1 dr) (Scheme 1-62).
61
 A variety of enals (except n-hexenal) 
and chalcones were tolerated in this reaction, affording the desired products in good yield 
(50-82%) with excellent enantioselectivities (typically 99% ee). The authors believed that the 
s-cis conformation arose from the coordination of the enal and chalcone oxygens to the 
titanium Lewis acid. 
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Scheme 1-62. Reaction of enals and chalcones by Scheidt’s group 
 
In 2014, Nair’s group disclosed a cinnamaldehyde tethered to a chalcone substrate, which can 
undergo homoenolate reactions under the catalysis of NHC to produce a 
cyclopentene-bearing macrocycles 1.245 (Scheme 1-63).
62
 
Scheme 1-63. Macrocyclization via cyclopentene synthesis 
 
In 2014, a unique strategy for the synthesis of biological important spiro-heterocyclic 
compounds was introduced by Glorius and co-workers (Scheme 1-64).
63
 Aurones and 
aza-aurones under the catalysis of NHC provided access to [3 + 2] annulation via C-acylation, 
giving the spiro-heterocyclic derivatives 1.248 bearing a quaternary stereogenic center with 
high enantioselectivity (up to 95% ee). 
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Scheme 1-64. Spiro-heterocyclic compounds formed via C-acylation 
 







 groups independently reported the difficult to access [4+3] 
annulation reactions by using α,β-unsaturated aldehydes and ortho-quinone methides 
(Scheme 1-65). Due to simple ortho-quinone methides are unstable, the Ye group utilized 
electron-rich and stable 1,3-benzodioxole-derived o-quinone methides 1.249 as the sarting 
material, and the Scheidt group employed a dual Lewis base activation strategy to generate 
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the ortho-quinone methides in situ. Benzoxopinones are produced in excellent 
enantioselectivity (up to 98% ee) in both reactions. 
 
1.3.4 New Precursors for Homoenolates  
Although most of the homoenolates are generated from enals, chemists are trying to find 
alternate access to homoenolates to overcome some drawbacks caused by enals. 
In 2009, Bode’s group used the α-hydroxyenones to replace enals to generate homoenolates 
for annulation reactions (Scheme 1-66).
66
 α-Hydroxyenones 1.255 can be prepared easily 
from commercial materials. And substrates bearing nitrogen heterocycles can also be made 
and included in the substrate scope. Besides, side reactions such as decomposition or 
dimerization of the enals can be avoided. However, due to the increased steric of these 
substrates, they are presently compatible with less bulky racemic catalysts. 
 
Scheme 1-66. NHC catalyzed α-hydroxyenones to generate homoenolates for annulation 
In 2013, Chi and colleagues tried to activate the inert β-carbons of saturated esters through 
NHCs (Scheme 1-67).
67
 Using this methodology, the catalytically generated homoenolates 
could undergo nucleophilic addition to electrophiles such as enones and imines. When 
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different enones were used as the coupling partners, aliphatic and aryl esters were tolerated as 
the homoenolate precursors, giving cyclopentene products 1.262 in 8−76% yield, 5:1 to 17:1 
dr, and 82−96% ee. γ-Lactones 1.263 could also be synthesized in 29−80% yield, 1.3:1 to 
4.5:1 dr and 68−92% ee by using trifluoroketones as the electrophiles. While hydrazones 
reacted as the electrophiles, γ-Lactams 1.264 were formed in 55−76% yield, 4:1 to 7:1 dr, and 
90−96% ee. 
Scheme 1-67. Homoenolates generated from saturated esters 
 
The reaction is proposed to start with addition of the carbene to the electron-deﬁcient aryl 
ester, generating acyl azolium 1.266, which undergoes deprotonations by base to give enolate 
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1.267. Then a proton transfers from the β-carbon to the enolate oxygen, furnishing 
homoenolate (Scheme 1-68). 
 
Scheme 1-68. Proposed mechanism 
 
1.4 Conclusion and Future Perspectives 
It is clear that NHC catalysis has had very important influence on organocatalysis. It provides 
us an easy method to access different member ring compounds through various annulation 
reactions. However, challenge still exists. Designing more efficient NHC catalysts for new 
type of reactions or different catalytic modes will be a major focus in this area. 
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Chapter 2 Stereoselective Synthesis of ε-Lactones or 
Spiro-Heterocycles through NHC-Catalyzed 
Annulation: Divergent Reactivity by Catalyst 
Control 
2.1 Introduction 
The seven member ring core fused with benzofuran and indole are found in biologically 











 (Figure 2-1). Remarkably, structurally 





Figure 2-1. Biologically active seven member rings compounds fused with benzofuran and indole 
The efficient construction of this heterocyclic moiety has attracted much attention due to their 
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structural importance in drug discovery and medicinal chemistry. Recently, many methods 
towards the synthesis of seven-membered compounds have been developed such as Bayer–
Villiger reaction,
74
 cyclocarbonylation catalyzed by transition metal,
75
 or ring expansion
76
. 
However, the intermolecular formation of the benzofuran and indole fused seven member 
ring especially contains heteroatoms has remained rare. 
Over the past decade, N-heterocyclic carbene (NHC) catalysis has been developed into a 
powerful tool for a wide range of annulation reactions (Scheme 2-1).
5,7,46,77
 The reaction of 
NHC with functionalized aldehydes could gave the Breslow intermediate 2.1, which may 
serve as either azolium enolate or homoenolate to engage different electrophiles, such as 
ketones, imines, or Michael acceptors. The [3+2] annulation of enals with aldehydes was first 
reported by Bode group and the Glorius group in 2004 and was extensively developed by 
many other groups later.
16,49,58,60,78
. The formal [3+3] annulations were demonstrated by many 
groups, following the pioneering work from the Scheidt group in 2007.
56-57,79
 They first 
employed enals to react with azomethines or nitrones for [3+3] annulation. For [2+4] 
annulation, enals could react with Michael acceptors under NHC catalysis very effectively for 
the preparation of δ-lactones and δ-lactams.31-32,37-40,42,80 Very recently, a formal [3+4] 
annulation of enals with o-quinone methides provided the difficult-to-access ε-lactones very 
effectively.
64-65
 It was believed that aromatization was a driving force to induce 
7-member-ring formation. 
Scheme 2-1. Previous work: a wide range of ring structures through NHC-catalyzed 
annulation of enals 
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While Ye and co-workers reported highly enantioselective synthesis of benzo-ε-lactones 
through N-heterocyclic carbene catalyzed [4+3] annulation of enals and o-quinone methides 
(Scheme 2-2. a),
64
 Scheidt group developed an innovative dual lewis base activation strategy 
for enantioselective carbene catalyzed annulations (Scheme 2-2. b).
65
 However, this 
methodology could not be applied to o-quinone methides bearing electron-withdrawing 
groups because of its high unstability. In addition, N-heterocyclic carbene (NHC)-catalyzed 
[3+4] cycloaddition of azomethine imines was reported by Chi’s group (Scheme 2-2. c).81  
Heterocyclic enones such as 2.11 (Scheme 2-3) has attracted my attention for stereoselective 
annulation reactions, as they can be prepared very easily and are also very stable, and more 
importantly the relatively electron-rich enone that in the same time possesses enol/enamine 
character may lead to divergent reactivity, which is highly valuable for synthetic strategies.
82
 
Combining with my interest in NHC catalysis,
83
 I decided to employ 2.11 to react with enals, 
with the hope that under different conditions I could get different valuable spirocyclic (such 
as 2.12) or tricyclic products (such as 2.13). 
PHD DISSERTATION 2016                                                                   WANG MIN 
52 
Scheme 2-2. Reported formal [4+3] annulation reactions 
 
While the Ye group and Scheidt group has reported the formation of related benzene-fused 
ε-lactones,64-65 it is noteworthy that the generation of spiro-cycles through the attack of the 
acyl azolium intermediate by a carbon-based nucleophile remains rare in NHC catalysis 
compared to all the previous systems that give lactones or lactams.
59,63,80e,84
 
Herein I report an interesting catalyst-controlled divergent reaction leading to high 
enantioselective synthesis of either benzofuran/indole-fused ε-lactones 2.13 or spiro 
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heterocycles 2.12. 




2.2 Results and Discussion 
2.2.1 Reaction Optimization of ε-Lactones 
Experimentally, I initiated the NHC catalyzed reaction by using heterocyclic enone 2.14a and 
enal 2.15a as the starting materials (Table 2-1). At beginning, the use of azolium salts 2.18 
and 2.19 with DBU as the base led to low conversion (entries 1-2), however, to my delight, 
the desired annulation reaction proceeded well in the presence of triazolium salt 2.20 to 
afford the formal [3+4] annulation product ε-lactone 2.16a as the major product (>20:1 dr) 
together with spirocycle 2.17a (formal [3+2] annulation product; entry 3) in a ratio of 3:1. I 
continued to screen a wide range of organic and inorganic bases, as a result, DBU was proved 
to be the optimal choice (entries 4-5; see Experimental Section for more details). Toluene 
was identified as a better choice after screening different solvents in terms of chemo- and 
stereoselectivity, albeit with low reactivity (entry 6; see Experimental Section for more 
details). 
PHD DISSERTATION 2016                                                                   WANG MIN 
54 














1 2.18 DBU DCM / / <5 / 
2 2.19 DBU DCM / / <5 / 
3 2.20 DBU DCM 3:1 > 20:1 80 89 
4 2.20 Et3N DCM 1.5:1 > 20:1 72 79 
5 2.20 KOAc DCM 2.5:1 > 20:1 26 83 
6 2.20 DBU PhMe 18:1 > 20:1 25 91 
[a] Reaction conditions: 2.14a (0.1 mmol), 2.15a (0.2 mmol), 20 mol% of triazolium salt, 30 mol% of base in 
solvent (1.0 mL) at 23 °C for 16 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 MHz) of 
the unpurified reaction mixture. [c] Isolated yield. [d] Determined by HPLC. 
 
 
In order to improve the efficiency of the catalytic system, I decided to try the cooperative 
catalysis by combining NHC and Lewis acid that was pioneered by the Scheidt group and 
later extended by many other groups.
50,61,83,85
 As shown in Table 2-2, after addition of a few 
different Lewis acids, the conversion was all increased, although chemo-selectivity was 
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reduced. Ti(Oi-Pr)4 was proved to be optimal to yield 2.16a in 72% yield with 91% ee. 












1 None 18 : 1 > 20:1 25 91 
2 Mg(Ot-Bu)2 4: 1 > 20:1 52 91 
3 Ti(Oi-Pr)4 10 : 1 > 20:1 72 91 
4 Sc(OTf)3 8 : 1 > 20:1 65 91 
[a] Reaction conditions: 2.14a (0.1 mmol), 2.15a (0.2 mmol), 20 mol% of triazolium salt 2.20, 30 mol% of 
DBU in PhMe (1.0 mL) at 23 °C for 16 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 
MHz) of the unpurified reaction mixture. [c] Isolated yield. [d] Determined by HPLC. 
 
2.2.2 Substrate Scope of ε-Lactones 
With the optimized reaction conditions in hand, the substrate scope of this catalytic system 
turned out to be rather broad. A wide range of 2.14 and 2.15 could be used successfully for 
the annulation reactions (Scheme 2-4). The easily accessible and stable coumaranone 
derivatives 2.14 bearing ortho-, meta- or para-substituents of both electron-rich and poor 
characters as well as heterocycles could proceed smoothly to yield the corresponding product 
2.16 in high chemo-, diastereo- and enantioselectivity (2.16a-2.16h). Besides, different enals 
2.15 bearing simple alkyl or ether-containing substituents can also be tolerated in this 
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reaction and give similarly good results (2.16i-2.16m). Cinnamaldehyde was also tested, 
which gave the desired product 3n in good yield and slightly diminished chemo- and 
stereoselectivity. It is noteworthy that the reaction gave ε-lactone 2.16 as a single 
syn-diastereomer in all cases except for 2.16n (5:1 dr), which is presumably resulted from 
steric repulsion of the two aryl rings. 
Remarkably, indole-fused ε-lactone could also be produced by my catalytic system, thus 
dramatically expanding the scope of this catalytic system (Scheme 2-5).  In all cases, only a 
single diastereomer of ε-lactone products was formed and I did not obtain any spirocyclic 
products for this series. Again, a wide range of substituents on the aryl ring in 2.21 and the 
substituents in enal 2.15 could proceed very well in this reaction (2.22a-2.22g). The relative 
and absolute configuration of 2.22g (98% ee after one recrystalization) was unambiguously 
assigned by single-crystal X-ray diffraction analysis. Considering the formation of 2.16 and 
2.22 goes through similar reaction mechanism, and 2.16 and 2.22 share the same NMR 
characters, all the other ε-lactones were assigned to have the same absolute configuration as 
2.22g. 
Scheme 2-4. Scope of benzofuran-fused ε-lactones 
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Unless otherwise noted, the reactions of 2.14 (0.2 mmol) and 2.15 (0.4 mmol) in the presence of 20 mol% of 
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2.20, 30 mol% of DBU and 10 mol% Ti(Oi-Pr)4 were carried out in toluene (2.0 mL) at 23
 oC for 16 h. 2.16 
were isolated as a single diastereomer (>20:1 dr) in all cases except for 3n (dr = 5:1). 
Scheme 2-5. Scope of indole-fused ε-lactones 
 
2.2.3 Reaction Optimization of Spiro-Heterocycles 
Interestingly, during the preparation of the racemic sample of 2.16 and 2.17 using the achiral 
azolium salt 2.23, I found that the reaction yielded spirocycle 2.17b as the major product 
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instead of 2.16b (entry 1, Table 2-3). This led us to speculate that the chemo-selectivity of 
the annulation might depend on the backbone of the azolium. When the closely related chiral 
catalyst 2.24 and 2.25 were examined, to my delight, the reaction gave 2.17b as the major 
product with a promising level of diastereo- and enantioselectivity (entries 2-3).  












1 10 DBU 1:3 13:1 56 / 
2 11 DBU 1:2 11:1 49 82 
3 12 DBU 1:4 15:1 51 78 
4 12 DIPEA 1:5 7:1 60 81 
5 12 DABCO 1:6 8:1 70 84 
[a] Reaction conditions: 2.14b (0.1 mmol), 2.15a (0.2 mmol), 20 mol% of azolium salt, 30 mol% of base in 
DCM (1.0 mL) at 23 °C for 48 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 MHz) of the 
unpurified reaction mixture. [c] Isolated yield. [d] Determined by HPLC. 
 
2.2.4 Substrate Scope of Spiro-Heterocycles 
After optimization of the reaction condition, I identified DABCO as the best choice of base 
(entry 5 vs. entries 3 & 4). A few representative spiro heterocycles 2.17b, 2.17c and 2.17k 
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can be produced under the optimized conditions in moderate to good yield with good 
enantioselectivity (Scheme 2-6). 
Scheme 2-6. Scope of spiro-heterocycles 
 
 
2.2.5 Proposed Mechanism  
Based on the chemo-divergent and stereochemical outcome as well as the related previous 
studies from the Scheidt and Ye groups, a stepwise mechanism was proposed shown in Figure 
2-2 (with catalyst 2.20). Carbene catalyst attacks the enal to form the homoenolate 
intermediate I, which goes through addition to the heterocyclic enone to produce enolate III. 
The configuration of the newly formed stereogenic centers in enolate III is established under 
the control of the chiral catalyst (as shown in transition state model II). The level of 
enantioselectivity of ε-lactone and spirocycle was essentially the same, which implies that the 
two series go through the same intermediate. For the enals bearing linear aliphatic substituent 
R, the product was obtained in >20:1 dr; when R is a more bulky aromatic group (as in 
PHD DISSERTATION 2016                                                                   WANG MIN 
61 
2.16n), lower diastereoselectivity was obtained, which might result from the steric repulsion 
among R, Ar and the heterocyclic backbone. In the final step, the chemo-selectivity is 
determined by the O- or C-alkylation of enolate 2.11. The observation of opposite selectivity 
from two catalysts is quite intriguing, and I think further mechanistic and computational 
studies may help the understanding of the origin of this divergent reactivity. 
 
 
Figure 2-2. Proposed catalytic cycle 
 
2.3 Conclusions  
In conclusion, I obtained benzofuran/indole-containing ε-lactones or spiro-heterocycles in a 
highly diastereo- and enantioselective fashion from NHC-catalyzed divergent annulations of 
enals with heterocyclic enones. Further work about the understanding of the 
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catalyst-controlled divergent reactivity in this process and the development of other 
NHC-catalyzed annulations are currently ongoing in my laboratories. 
2.4 Experimental Section 
2.4.1 General Information 
Thin layer chromatography (TLC) was performed on Merck pre-coated TLC plates (Merck 
60 F254), and compounds were visualized with a UV light at 254nm. Further visualization 
was achieved by staining with iodine, or potassium permanganate solution followed by 
heating using a heat gun. Flash chromatography separations were performed on Merck 60 




C NMR spectra were recorded on a Bruker 
ACF300 (300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0) or tetramethylsilane (TMS δ 0.00) 
was used as a reference. Data are reported as follows: chemical shift, multiplicity (s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants (Hz) and 
integration.  High resolution mass spectra (HRMS) were obtained on a Finnigan/MAT 
95XL-T spectrometer. Optical rotations were recorded on an mrc AP81 automatic 
polarimeter.  Enantiomeric excesses (ee) were determined by HPLC analysis on Agilent 
HPLC units, including the following instruments: pump, LC-20AD; detector, SPD-20A; 
column, Chiralpak AS-H, IA, IB, IC or ID.  
All reactions were carried out under nitrogen atmosphere. All solvents were purified and 
dried according to standard methods prior to use. NHC precursors 2.18, 2.19, 2.20, 2.23, 2.24, 
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2.25, 2.26 and 2.27 were prepared according to literatures.
31,67,86
 The starting materials were 
prepared based on the general procedure.
87
 















1 2.18 DBU DCM 18:1 > 20:1 - < 5 
2 2.19 DBU DCM 18:1 > 20:1 - < 5 
3 2.20 DBU DCM 3:1 > 20:1 89 80 
4 2.20 CsCO3 DCM 1:3 > 20:1 73 52 
5 2.20 Et3N DCM 1.5:1 > 20:1 79 72 
6 2.20 KOAc DCM 2.5:1 > 20:1 83 26 
7 2.20 KO
t
Bu DCM 1:1.3 > 20:1 83 44 
8 2.20 K2CO3 DCM 2:1 > 20:1 - < 5 
9 2.20 DIPEA DCM 2:1 > 20:1 - < 5 
10 2.20 DABCO DCM 1.5:1 > 20:1 - < 5 
11 2.20 DBU Ether 6:1 > 20:1 87 59 
12 2.20 DBU CH3CN 3:1 > 20:1 77 72 
13 2.20 DBU Dioxane 10:1 > 20:1 87 52 
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14 2.20 DBU Toluene 18:1 > 20:1 91 25 
15 2.20 DBU DME 7:1 > 20:1 89 46 
16 2.20 DBU THF 5:1 > 20:1 85 35 
[a] Reaction conditions: 2.14a (0.1 mmol), 2.15a (0.2 mmol), 20 mol % of triazolium salt, 30 mol % of base 
in solvent (1.0 mL) at 23oC for 16 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 MHz) 
of the unpurified reaction mixture. [c] Determined by HPLC. [d] Isolated yield. 
 
2.4.3 General Procedure for N-heterocyclic Carbene-Catalyzed 
[3+4] Annulation 
 
To a 4 mL vial was added 2.14 or 2.21 (0.20 mmol), triazolium salt 2.20 (16.8 mg, 0.040 
mmol). The mixture was taken into the glovebox, where anhydrous toluene (2.0 mL), 2.15 
(0.40 mmol), titanium isopropoxide (6.0 μL, 0.020 mmol) and DBU (9.0 μL, 0.060 mmol) 
were added using a micropipette. The reaction mixture was taken outside the glovebox, the 
vial was then sealed and the reaction mixture was allowed to stir at ambient temperature for 
the period of time as indicated in Schemes 2-4 and 2-5. The crude reaction mixture was 
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directly purified by silica gel column chromatography to afford the desired product 2.16 or 
2.22. 
2.4.4. Analytical data of enantioselective [3+4] annulation 
products 
(4S,5R)-4-ethyl-5-phenyl-4,5-dihydrobenzofuro[3,2-b]oxepin-2(3H)-one (2.16a). 
 Pale yellow viscous oil, 72% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 7.69 – 7.67 (m, 1H), 7.36 – 7.27 (m, 6H), 7.10 (d, J = 6.0 
Hz, 2H), 4.59 (d, J = 6.0 Hz, 1H), 3.17 (dd, J = 15.5, 9.0 Hz, 1H), 
2.75 (d, J = 15.0 Hz, 1H), 2.45 – 2.40 (m, 1H), 1.49 – 1.44 (m, 1H), 
1.20 – 1.13 (m, 1H), 1.00 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 169.9, 152.2, 
141.2, 137.7, 134.1, 129.2, 128.5, 127.5, 125.3, 123.0, 122.3, 118.5, 111.3, 48.5, 37.4, 36.6, 
24.3, 12.1. HRMS (EI) m/z Calcd for [C20H18O3, M]
+
: 306.1256; Found: 306.1264.  
Optical Rotation: [α]21D = -21.8 (0.3, CHCl3). 91% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.42 




 Pale yellow viscous oil, 85% yield, dr > 20:1. 
1
H NMR (300 MHz, 
CDCl3): δ 7.69 – 7.62 (m, 2H), 7.30 – 7.28 (m, 3H), 7.25 – 7.14 (m, 
2H), 6.85 (dd, J = 7.2, 2.1 Hz, 1H), 5.06 (d, J = 7.2 Hz, 1H), 3.27 
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(dd, J = 14.7, 7.8 Hz, 1H), 2.99 (d, J = 15.0 Hz, 1H), 2.74 – 2.65 (m, 1H), 1.32 – 1.20 (m, 
2H), 0.91 (t, J = 7.2 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 169.5, 152.3, 141.1, 137.6, 
134.1, 133.2, 131.1, 129.0, 127.3, 125.4, 124.3, 123.1, 122.3, 118.5, 111.3, 49.4, 37.6, 34.2, 
22.2, 12.0. HRMS (EI) m/z Calcd for [C20H17O3Br, M]
+
: 384.0361; Found: 384.0348. 
Optical Rotation: [α]25D = +38.7 (0.9, CHCl3). 95% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 8.49 min 




 Pale yellow viscous oil, 82% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.66 – 7.64 (m, 1H), 7.29 – 7.25 (m, 4H), 6.95 (d, 
J = 7.5 Hz, 1H), 6.86 (t, J = 7.5 Hz, 1H), 6.79 (d, J = 7.0 Hz, 1H), 
5.04 (d, J = 6.0 Hz, 1H), 3.87 (s, 3H), 3.21 (dd, J = 15.5, 8.5 Hz, 
1H), 2.88 (d, J = 14.5 Hz, 1H), 2.57 – 2.51 (m, 1H), 1.38 – 1.32 (m, 1H), 1.21 – 1.14 (m, 1H), 
0.91 (t, J = 7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 170.2, 157.0, 152.1, 142.2, 134.0, 
130.2, 128.5, 126.5, 125.0, 122.9, 122.5, 120.3, 118.3, 111.2, 110.6, 55.4, 42.9, 37.4, 35.3, 
22.9, 12.1. HRMS (EI) m/z Calcd for [C21H20O4, M]
+
: 336.1362; Found: 336.1367. 
Optical Rotation: [α]24D = +43.8 (0.5, CHCl3). 93% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.71 
min for minor isomer, tR = 17.38 min for major isomer).  
 




 Pale yellow viscous oil, 78% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 – 7.66 (m, 1H), 7.47 (d, J = 8.0 Hz, 2H), 
7.33 – 7.26 (m, 3H), 6.97 (d, J = 9.0 Hz, 2H), 4.55 (d, J = 5.5 
Hz, 1H), 3.12 (dd, J = 16.0, 9.0 Hz, 1H), 2.76 (d, J = 15.0 Hz, 
1H), 2.43 – 2.37 (m, 1H), 1.46 – 1.39 (m, 1H), 1.20 – 1.13 (m, 
1H), 1.00 (t, J = 6.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 169.6, 152.2, 140.5, 136.8, 
134.1, 131.7, 130.8, 125.5, 123.1, 122.2, 121.6, 118.6, 111.3, 48.1, 37.2, 36.6, 24.1, 12.0. 
HRMS (EI) m/z Calcd for [C20H17O3Br, M]
+
: 384.0361; Found: 384.0343. 
Optical Rotation: [α]25D = -25.8 (0.2, CHCl3). 95% ee. (HPLC condition: Chiralpark IB 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.56 




Pale yellow viscous oil, 63% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 7.68 – 7.66 (m, 1H), 7.30 – 7.27 (m, 3H), 7.01 (d, J = 
8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 4.54 (d, J = 5.5 Hz, 1H), 
3.80 (s, 3H), 3.14 (dd, J = 15.0, 9.0 Hz, 1H), 2.71 (d, J = 15.0 Hz, 
1H), 2.41 – 2.35 (m, 1H), 1.51 – 1.45 (m, 1H), 1.19 – 1.13 (m, 1H), 1.01 (t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 170.0, 158.9, 152.1, 141.5, 133.9, 130.2, 129.7, 125.3, 123.0, 
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122.3, 118.5, 113.9, 111.3, 55.2, 47.6, 37.5, 36.5, 24.4, 12.1. HRMS (EI) m/z Calcd for 
[C21H20O4, M]
+
: 336.1362; Found: 336.1367. 
Optical Rotation: [α]24D = -52.3 (0.3, CHCl3). 93% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 18.09 




Pale yellow viscous oil, 77% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 7.69 – 7.68 (m, 1H), 7.31 – 7.28 (m, 4H), 6.86 (dd, J = 
8.0, 2.5 Hz, 1H), 6.69 (d, J = 7.5 Hz, 1H), 6.66 – 6.66 (m, 1H), 
4.57 (d, J = 5.5 Hz, 1H), 3.79 (s, 3H), 3.20 (dd, J = 15.5, 9.0 Hz, 
1H), 2.76 (d, J = 15.0 Hz, 1H), 2.45 – 2.40 (m, 1H), 1.52 – 1.47 (m, 1H), 1.23 – 1.16 (m, 1H), 
1.01 (t, J = 7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 169.9, 159.7, 152.2, 141.1, 139.3, 
134.0, 129.5, 125.3, 123.0, 122.3, 121.6, 118.5, 115.7, 112.2, 111.3, 55.2, 48.5, 37.3, 36.6, 
24.3, 12.1. HRMS (EI) m/z Calcd for [C21H20O4, M]
+
: 336.1362; Found: 336.1371. 
Optical Rotation: [α]25D = -18.7 (0.7, CHCl3). 90% ee. (HPLC condition: Chiralpak IA 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 14.20 
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Pale yellow viscous oil, 76% yield, dr > 20:1.
 1
H NMR (500 
MHz, CDCl3): δ 7.69 – 7.67 (m, 1H), 7.32 – 7.28 (m, 5H), 7.10 
(t, J = 2.0 Hz, 1H), 6.97 (dt, J = 7.0, 1.5 Hz, 1H), 4.57 (d, J = 
5.5 Hz, 1H), 3.15 (dd, J = 15.0, 9.0 Hz, 1H), 2.78 (d, J = 15.0 
Hz, 1H), 2.43 – 2.38 (m, 1H), 1.46 – 1.41 (m, 1H), 1.19 – 1.16 
(m, 1H), 1.00 (t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 169.5, 152.2, 140.3, 139.9, 
134.5, 134.1, 129.7, 129.2, 127.8, 127.3, 125.5, 123.1, 122.2, 118.6, 111.3, 48.4, 37.2, 36.6, 
24.0, 12.0. HRMS (EI) m/z Calcd for [C20H17O3Cl, M]
+
: 340.0866; Found: 340.0854. 
Optical Rotation: [α]25D = -22.2 (0.5, CHCl3). 94% ee. (HPLC condition: Chiralpak AS-H 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 19.06 




 Pale yellow viscous oil, 85% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 – 7.63 (m, 2H), 7.31 – 7.27 (m, 3H), 7.22 
(td, J = 7.0, 1.5 Hz, 1H), 7.18 (td, J = 7.5, 2.0 Hz, 1H), 6.86 (d, J 
= 7.5 Hz, 1H), 5.06 (d, J = 6.5 Hz, 1H), 3.23 (dd, J = 15.0, 8.0 
Hz, 1H), 2.98 (d, J = 15.5 Hz, 1H), 2.84 – 2.78 (m, 1H), 1.54 – 1.48 (m, 1H), 1.15 – 1.07 (m, 
2H), 0.94 – 0.86 (m, 1H), 0.78 (t, J = 8.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 169.6, 
152.3, 141.1, 137.6, 134.1, 133.2, 131.2, 129.0, 127.3, 125.4, 124.3, 123.1, 122.3, 118.5, 
111.3, 49.3, 38.0, 32.1, 31.1, 20.3, 13.8. HRMS (EI) m/z Calcd for [C21H19O3Br, M]
+
: 
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398.0518; Found: 398.0503. 
Optical Rotation: [α]25D = +32.8 (0.8, CHCl3). 92% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 7.18 min 




 Pale yellow viscous oil, 61% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 – 7.66 (m, 1H), 7.64 (dd, J = 8.0, 1.0 Hz, 
1H), 7.31 – 7.27 (m, 3H), 7.22 (td, J = 7.0, 1.5 Hz, 1H), 7.17 (td, 
J = 8.0, 2.0 Hz, 1H), 6.86 (dd, J = 7.5, 2.0 Hz, 1H), 5.05 (d, J = 
7.0 Hz, 1H), 3.24 (dd, J = 14.5, 7.5 Hz, 1H), 2.98 (d, J = 15.0 Hz, 1H), 2.80 – 2.77 (m, 1H), 
1.47 – 1.44 (m, 1H), 1.24 – 1.12 (m, 4H), 1.09 – 1.03 (m, 1H), 0.77 (t, J = 7.5 Hz, 3H). 13C 
NMR (125 MHz, CDCl3): δ 169.6, 152.3, 141.1, 137.6, 134.1, 133.2, 131.2, 129.0, 127.3, 
125.4, 124.3, 123.1, 122.3, 118.5, 111.3, 49.4, 38.1, 32.2, 29.2, 28.6, 22.4, 13.7. HRMS (EI) 
m/z Calcd for [C22H21O3Br, M]
+
: 412.0674; Found: 412.0666. 
Optical Rotation: [α]26D = +54.8 (0.3, CHCl3). 91% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 6.52 min 
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Pale yellow viscous oil, 62% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 – 7.66 (m, 1H), 7.63 (dd, J = 7.5, 1.5 Hz, 
1H), 7.30 – 7.27 (m, 3H), 7.22 – 7.15 (m, 2H), 7.01 (dd, J = 7.5, 
2.0 Hz, 1H), 5.07 (d, J = 7.5 Hz, 1H), 3.61 (dd, J = 10.0, 3.0 Hz, 
1H), 3.33 (dd, J = 10.5, 6.5 Hz, 1H), 3.16 (dd, J = 14.5, 8.0 Hz, 1H), 3.01 (d, J = 14.0 Hz, 
1H), 2.99 – 2.96 (m, 1H), 0.80 (s, 9H), -0.06 (s, 3H), -0.13 (s, 3H). 13C NMR (125 MHz, 
CDCl3): δ 169.7, 152.1, 141.1, 137.5, 134.1, 133.0, 131.2, 129.0, 127.4, 125.2, 124.2, 123.0, 
122.5, 118.5, 111.1, 61.9, 46.7, 36.7, 35.9, 25.8, 18.2, -6.0, -6.0. HRMS (EI) m/z Calcd for 
[C25H29O4BrSi, M]
+
: 500.1018; Found: 500.1006. 
Optical Rotation: [α]24D = +2.6 (0.2, CHCl3). 90% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 5.85 min 




Pale yellow viscous oil, 75% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 – 7.67 (m, 1H), 7.64 (d, J = 7.5 Hz, 1H), 
7.31 – 7.29 (m, 3H), 7.28 – 7.21 (m, 1H), 7.17 (td, J = 7.5, 2.0 
Hz, 1H), 6.86 (d, J = 7.0 Hz, 1H), 5.08 (d, J = 7.0 Hz, 1H), 
3.61 – 3.51 (m, 2H), 3.23 (dd, J = 15.0, 8.0 Hz, 1H), 3.17 – 3.11 (m, 1H), 3.00 (d, J = 15.0 
Hz, 1H), 1.46 – 1.42 (m, 2H), 0.84 (s, 9H), -0.02 (s, 3H), -0.06 (s, 3H). 13C NMR (125 MHz, 
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CDCl3): δ 169.7, 152.3, 141.2, 137.5, 134.2, 133.3, 131.0, 129.0, 127.3, 125.4, 124.4, 123.1, 
122.3, 118.5, 111.3, 59.6, 49.1, 37.8, 31.7, 28.1, 25.8, 18.1, -5.4, -5.5. HRMS (EI) m/z Calcd 
for [C26H31O4BrSi, M]
+
: 514.1175; Found: 514.1189. 
Optical Rotation: [α]24D = +41.5 (0.7, CHCl3). 93% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 5.09 min 




Pale yellow viscous oil, 65% yield, dr > 20:1.
 1
H NMR (500 
MHz, CDCl3): δ 7.69 – 7.67 (m, 1H), 7.65 (dd, J = 8.0, 1.0 Hz, 
1H), 7.35 – 7.28 (m, 8H), 7.22 (td, J = 7.5, 1.0 Hz, 1H), 7.17 
(td, J = 8.0, 2.0 Hz, 1H), 6.87 (d, J = 6.5 Hz, 1H), 5.10 (d, J = 
7.0 Hz, 1H), 4.39 (q, J = 12.0 Hz, 2H), 3.48 – 3.37 (m, 2H), 3.19 (dd, J = 15.0, 8.0 Hz, 1H), 
3.15 – 3.10 (m, 1H), 3.00 (d, J = 14.5 Hz, 1H), 1.65 – 1.62 (m, 1H), 1.60 – 1.51 (m, 1H). 13C 
NMR (125 MHz, CDCl3): δ 169.6, 152.3, 141.0, 138.2, 137.4, 134.2, 133.3, 131.0, 129.1, 
128.3, 127.6, 127.5, 127.4, 125.5, 124.4, 123.1, 122.2, 118.5, 111.3, 72.8, 67.1, 48.9, 37.9, 
28.9, 28.8. HRMS (EI) m/z Calcd for [C27H23O4Br, M]
+
: 490.0780; Found: 490.0761. 
Optical Rotation: [α]24D = +42.7 (0.7, CHCl3). 89% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 15.52 
min for major isomer, tR = 16.89 min for minor isomer).  
 





 Pale yellow viscous oil, 70% yield, dr = 5:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.75 – 7.73 (m, 1H), 7.42 (dd, J = 7.5, 1.5 Hz, 
1H), 7.35 – 7.31 (m, 3H), 7.18 – 7.08 (m, 4H), 7.06 – 7.02 (m, 
1H), 6.91 – 6.87 (m, 3H), 5.35 (d, J = 6.5 Hz, 1H), 4.16 (t, J = 
7.5 Hz, 1H), 3.56 (dd, J = 15.0, 9.5 Hz, 1H), 3.18 (d, J = 13.5 Hz, 1H). 
13
C NMR (125 MHz, 
CDCl3): δ 169.1, 152.2, 140.7, 138.6, 136.6, 134.4, 132.9, 131.0, 128.9, 128.8, 128.3, 127.5, 
127.0, 125.9, 125.7, 123.2, 122.2, 118.7, 111.4, 47.4, 40.9, 39.3. HRMS (EI) m/z Calcd for 
[C24H17O3Br, M]
+
: 432.0361; Found: 432.0344. 
Optical Rotation: [α]24D = -75.5 (0.7, CHCl3). 83% ee. (HPLC condition: Chiralpak IB 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 16.37 





 Pale yellow viscous oil, 61% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 7.68 (d, J = 7.0 Hz, 1H), 7.40 (s, 1H), 7.36 – 7.28 (m, 3H), 
6.40 (t, J = 2.5 Hz, 1H), 6.20 (d, J = 2.0 Hz, 1H), 4.62 (d, J = 5.0 Hz, 
1H), 3.35 (dd, J = 15.0, 9.5 Hz, 1H), 2.69 (d, J = 15.0 Hz, 1H), 2.46 – 
2.40 (m, 1H), 1.53 – 1.44 (m, 1H), 1.34 – 1.29 (m, 1H), 1.08 (t, J = 7.5 Hz, 3H). 13C NMR 
(125 MHz, CDCl3): δ 170.1, 152.0, 151.4, 142.4, 139.2, 133.3, 125.4, 123.0, 122.3, 118.6, 
111.2, 110.3, 109.2, 41.2, 37.0, 36.5, 26.2, 12.0. HRMS (EI) m/z Calcd for [C18H16O4, M]
+
: 
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296.1049; Found: 296.1053. 
Optical Rotation: [α]27D = -9.8 (0.4, CHCl3). 92% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 95:5, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 9.05 min 
for major isomer, tR = 9.83 min for minor isomer). 
 
 (4S,5R)-4-ethyl-5-phenyl-3,4,5,6-tetrahydro-2H-oxepino[3,2-b]indol-2-one (2.22a). 
Pale yellow viscous oil, 91% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 7.72 – 7.71 (m, 1H), 7.37 – 7.32 (m, 4H), 7.21 – 7.17 (m, 
1H), 7.15 – 7.11 (m, 4H), 4.52 (d, J = 5.5 Hz, 1H), 3.15 (dd, J = 
15.0, 8.5 Hz, 1H), 2.72 (d, J = 15.5 Hz, 1H), 2.42 – 2.36 (m, 1H), 
1.43 – 1.38 (m, 1H), 1.20 – 1.13 (m, 1H), 0.98 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 171.1, 139.0, 133.0, 130.7, 129.6, 128.6, 127.7, 123.2, 122.1, 120.4, 119.9, 117.6, 
110.4, 48.4, 38.2, 36.7, 24.0, 12.1. HRMS (ESI) m/z Calcd for [C20H18NO2, M-H]
+
: 
304.1343; Found: 304.1335. 
Optical Rotation: [α]25D = -34.5 (0.8, CHCl3). 89% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 48.61 
min for minor isomer, tR = 67.11 min for major isomer). 
 
(4S,5R)-5-phenyl-4-propyl-3,4,5,6-tetrahydro-2H-oxepino[3,2-b]indol-2-one (2.22b). 
 Pale yellow viscous oil, 54% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.73 – 7.71 (m, 1H), 7.37 – 7.32 (m, 3H), 7.21 
– 7.18 (m, 1H), 7.16 – 7.13 (m, 4H), 4.53 (d, J = 5.5 Hz, 1H), 
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3.16 (dd, J = 15.0, 9.0 Hz, 1H), 2.72 (d, J = 15.5 Hz, 1H), 2.55 – 2.49 (m, 1H), 1.56 – 1.50 (m, 
1H), 1.35 – 1.23 (m, 2H), 1.18 – 1.13 (m, 1H), 0.84 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 171.2, 139.0, 133.1, 130.7, 129.6, 128.6, 127.7, 123.2, 122.1, 120.4, 119.9, 117.6, 
110.4, 48.5, 37.1, 36.1, 33.1, 20.5, 13.9. HRMS (ESI) m/z Calcd for [C21H20NO2, M-H]
+
: 
318.1500; Found: 318.1494. 
Optical Rotation: [α]26D = -31.0 (0.5, CHCl3). 89% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.16 




Pale yellow viscous oil, 72% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.74 – 7.72 (m, 1H), 7.34 – 7.29 (m, 4H), 7.20 
– 7.17 (m, 3H), 7.16 – 7.13 (m, 2H), 4.74 (d, J = 6.0 Hz, 1H), 
3.43 (dd, J = 10.0, 5.5 Hz, 1H), 3.29 (t, J = 9.0 Hz, 1H), 3.00 
(dd, J = 15.0, 9.5 Hz, 1H), 2.81 – 2.75 (m, 1H), 2.40 (d, J = 15.0 Hz, 1H), 0.93 (s, 9H), 0.07 (s, 
3H), 0.05 (s, 3H).
 13
C NMR (125 MHz, CDCl3): δ 171.0, 138.0, 133.0, 131.1, 129.9, 128.5, 
127.8, 123.3, 122.2, 120.4, 119.9, 117.7, 110.4, 63.2, 43.6, 38.3, 33.2, 25.8, 18.1, -5.5, -5.5. 
HRMS (ESI) m/z Calcd for [C25H30NO3Si, M-H]
+
: 420.2000; Found: 420.2001. 
Optical Rotation: [α]23D = -78.1 (0.9, CHCl3). 93% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 18.35 
min for minor isomer, tR = 21.72 min for major isomer). 




 Pale yellow viscous oil, 87% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 7.73 – 7.71 (m, 1H), 7.37 – 7.32 (m, 4H), 7.21 
– 7.17 (m, 1H), 7.15 – 7.12 (m, 4H), 4.55 (d, J = 6.0 Hz, 1H), 
3.63 (q, J = 4.0 Hz, 2H), 3.15 (dd, J = 15.0, 8.5 Hz, 1H), 2.81 – 
2.75 (m, 2H), 1.66 – 1.60 (m, 1H), 1.35 – 1.30 (m, 1H), 0.86 (s, 9H), 0.02 (s, 3H), -0.03 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ 171.0, 139.1, 133.1, 130.7, 129.6, 128.7, 127.7, 123.2, 122.0, 
120.4, 119.9, 117.6, 110.4, 60.1, 48.6, 37.0, 33.4, 32.2, 25.8, 18.1, -5.5, -5.5. HRMS (ESI) 
m/z Calcd for [C26H32NO3Si, M-H]
+
: 434.2157; Found: 434.2151. 
Optical Rotation: [α]24D = +12.2 (0.6, CHCl3). 91% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 15.45 




Pale yellow viscous oil, 78% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3 ): δ 7.72 (d, J = 8.5 Hz, 1H), 7.36 – 7.28 (m, 8H), 
7.21 – 7.10 (m, 5H), 4.50 (d, J = 5.5 Hz, 1H), 4.43 (s, 2H), 3.55 – 
3.49 (m, 2H), 3.14 (dd, J = 14.5, 8.5 Hz, 1H), 2.82 – 2.78 (m, 
1H), 2.76 (d, J = 15.0 Hz, 1H), 1.79 – 1.73 (m, 1H), 1.44 – 1.37 (m, 1H). 13C NMR (125 MHz, 
CDCl3): δ 171.0, 138.8, 138.1, 133.1, 130.7, 129.6, 128.7, 128.3, 127.7, 127.6, 127.6, 123.2, 
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122.0, 120.3, 119.9, 117.6, 110.4, 73.0, 67.4, 48.3, 36.8, 32.6, 30.9. HRMS (ESI) m/z Calcd 
for [C27H24NO3, M-H]
+
: 410.1762; Found: 410.1756. 
Optical Rotation: [α]25D = -12.2 (0.9, CHCl3). 90% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 22.81 




Pale yellow viscous oil, 81% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3 ): δ 7.71 (d, J = 7.5 Hz, 1H), 7.65 (dd, J = 7.5, 1.0 Hz, 1H), 
7.30 (s, 1H), 7.24 – 7.13 (m, 5H), 6.94 (dd, J = 7.5, 2.0 Hz, 1H), 
5.05 (d, J = 7.0 Hz, 1H), 3.22 (dd, J = 14.5, 8.0 Hz, 1H), 2.98 (d, J 
= 14.5 Hz, 1H), 2.65 – 2.59 (m, 1H), 1.36 – 1.28 (m, 1H), 1.23 – 1.18 (m, 1H), 0.91 (t, J = 
7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 170.7, 138.7, 133.3, 133.2, 131.5, 130.7, 129.2, 
127.5, 124.8, 123.3, 121.7, 120.4, 120.0, 117.6, 110.4, 48.7, 37.7, 34.9, 21.9, 12.1. HRMS 
(ESI) m/z Calcd for [C20H17BrNO2, M-H]
+
: 382.0448; Found: 382.0438. 
Optical Rotation: [α]26D = +61.4 (0.9, CHCl3). 90% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 32.37 
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 Pale yellow viscous oil, 64% yield, dr > 20:1. 
1
H NMR 
(500 MHz, CDCl3 ): δ 7.72 (d, J = 7.5 Hz, 1H), 7.65 (dd, J = 
7.5, 1.5 Hz, 1H), 7.34 – 7.31 (m, 2H), 7.28 – 7.26 (m, 4H), 
7.23 – 7.14 (m, 5H), 6.93 (dd, J = 7.0, 2.0 Hz, 1H), 5.07 (d, J 
= 6.5 Hz, 1H), 4.38 (q, J = 11.5 Hz, 2H), 3.49 – 3.40 (m, 2H), 3.15 (dd, J = 14.5, 7.5 Hz, 1H), 
3.06 – 2.98 (m, 2H), 1.60 – 1.56 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 170.7, 138.5, 
138.2, 133.4, 133.2, 131.4, 130.8, 129.3, 128.3, 127.6, 127.6, 127.5, 124.8, 123.4, 121.5, 
120.3, 120.0, 117.6, 110.5, 72.7, 67.3, 48.4, 37.9, 29.4, 28.8. HRMS (ESI) m/z Calcd for 
[C27H23BrNO3, M-H]
+
: 488.0867; Found: 488.0866. 
Optical Rotation: [α]24D = +53.4 (0.8, CHCl3). 86% ee (after recrystallization, 98% ee). 
(HPLC condition: Chiralpak ID column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, 
wavelength = 254 nm, tR = 17.92 min for minor isomer, tR = 24.08 min for major isomer). 
2.4. 5 Reaction Optimization for Enantioselective [3+2] 
Annulation 
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1 2.25 1:4 15:1 78 51 
2 2.26 1:3 8:1 75 31 
3 2.27 - - - <5% 
[a] Reaction conditions: 2.14 (0.1 mmol), 2.15 (0.2 mmol), 20 mol % of triazolium salt, 30 mol % of DBU in 
DCM (1.0 mL) at 23 oC for 48 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 MHz) of 
the unpurified reaction mixture. [c] Determined by HPLC. [d] Isolated yield of 2.17b. 
 
 
















1 DCM 1:4 15:1 78 51 
2 THF 1:2 8:1 82 28 
3 CH3CN 1:4 14:1 74 48 
4 CHCl3 - - - <5 
5 ether - - - <5 
6 dioxane - - - <5 
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[a] Reaction conditions: 2.14 (0.1 mmol), 2.15 (0.2 mmol), 20 mol % of triazolium salt 2.25, 30 mol % of 
DBU in solvents (1.0 mL) at 23 oC for 48 h, unless noted otherwise. [b] Determined by 1H NMR analysis 
(500 MHz) of the unpurified reaction mixture. [c] Determined by HPLC. [d] Isolated yield of 2.17b. 
 




Entry Base Ratio(2.16b/2.17b)b d.r. (2.17b)b ee (2.17b)c/% Yield(2.17b)d/% 
1 DBU 1:4 15:1 78 51 
2 CsCO3 1:3 7:1 81 45 
3 Et3N 1:4 5:1 81 42 
4 KOAc 1:5 7:1 79 33 
5 K2CO3 1:2 6:1 79 42 
6 DIPEA 1:5 7:1 81 60 
7 DABCO 1:6 8:1 84 70 
[a] Reaction conditions: 2.14 (0.1 mmol), 2.15 (0.2 mmol), 20 mol % of triazolium salt 2.25, 30 mol % of 
base in DCM (1.0 mL) at 23 oC for 48 h, unless noted otherwise. [b] Determined by 1H NMR analysis (500 
MHz) of the unpurified reaction mixture. [c] Determined by HPLC. [d] Isolated yield of 2.17b. 
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2.4.6. General Procedure for N-Heterocyclic Carbene-Catalyzed 
[3+2] Annulation 
 
To a 4 mL vial was added 2.14 (0.20 mmol), triazolium salt 2.25 (14.4 mg, 0.040 mmol). The 
mixture was taken into glovebox, where DABCO (6.8 mg, 0.060 mmol), anhydrous DCM 
(2.0 mL) and 2.15 (0.40 mmol) were added. The reaction mixture was taken outside the 
glovebox, the vial was then sealed and the reaction mixture was allowed to stir at ambient 
temperature for the period of time as indicated in Scheme 2-6. The crude reaction mixture 
was concentrated, then directly purified by silica gel column chromatography to afford the 
desired product 2.17. 
 




Pale yellow viscous oil, 70% yield, dr = 8:1. 
1
H NMR (500 MHz, 
CDCl3 ): δ 7.65 (d, J = 7.0 Hz, 1H), 7.61 – 7.58 (m, 2H), 7.28 – 7.25 
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(m, 1H), 7.14 – 7.08 (m, 4H), 4.61 (d, J = 7.0 Hz, 1H), 3.32 – 3.24 (m, 1H), 2.87 (dd, J = 
19.5, 9.5 Hz, 1H), 2.37 (dd, J = 20.0, 10.0 Hz, 1H), 1.66 – 1.59 (m, 1H), 1.05 – 0.96 (m, 1H), 
0.90 (t, J = 7.5 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ 208.3, 196.4, 172.5, 138.3, 135.3, 
133.4, 129.7, 128.7, 127.2, 126.3, 125.0, 122.8, 119.4, 113.5, 96.3, 50.2, 39.7, 37.2, 24.4, 
12.4. HRMS (EI) m/z Calcd for [C20H17O3Br, M]
+
: 384.0361; Found: 384.0349. 
Optical Rotation: [α]25D = +32.7 (0.8, CHCl3). 84% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.56 
min for minor isomer, tR = 15.90 min for major isomer). 
 
The cis relative configuration of 2.17a was determined by the NOE correlation between the 
Ha and Hb (Figure 2-3). The absolute configuration was not determined. 
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 Pale yellow viscous oil, 55% yield, dr >20:1. 
1
H NMR (500 MHz, 
CDCl3 ): δ 7.62 (d, J = 7.0 Hz, 1H), 7.55 – 7.52 (m, 1H), 7.29 – 
7.26 (m, 1H), 7.06 (t, J = 7.5 Hz, 1H), 7.02 – 6.91 (m, 2H), 6.89 – 
6.86 (m, 2H), 3.98 (d, J = 8.0 Hz, 1H), 3.72 (s, 3H), 3.21 – 3.16 (m, 
1H), 2.76 (dd, J = 19.5, 10.0 Hz, 1H), 2.32 (dd, J = 19.5, 9.0 Hz, 1H), 1.32 – 1.27 (m, 1H), 
1.01 – 0.94 (m, 1H), 0.88 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): δ 207.4, 198.1, 
172.8, 157.7, 138.0, 132.3, 128.7, 125.1, 124.7, 122.3, 120.5, 119.5, 113.6, 111.0, 96.9, 54.5, 
50.0, 40.0, 36.6, 25.6, 12.6. HRMS (EI) m/z Calcd for [C21H20O4, M]
+
: 336.1362; Found: 
336.1366. 
Optical Rotation: [α]25D = +92.6 (0.5, CHCl3). 79% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 17.00 
min for minor isomer, tR = 20.58 min for major isomer). 
 
cis-2'-(2-bromophenyl)-3'-(2-(tert-butyldimethylsilyloxy)ethyl)-3H-spiro[benzofuran-2,1
'-cyclopentane]-3,5'-dione  (2.17k) 
 Pale yellow viscous oil, 51% yield, dr = 5:1. 
1
H NMR (500 
MHz, CDCl3 ): δ 7.64 (d, J = 7.5 Hz, 1H), 7.60 – 7.58 (m, 2H), 
7.28 – 7.26 (m, 1H), 7.15 – 7.08 (m, 4H), 4.58 (d, J = 7.0 Hz, 
1H), 3.65 – 3.57 (m, 2H), 3.55 – 3.51 (m, 1H), 2.88 (dd, J = 
20.5, 9.5 Hz, 1H), 2.46 (dd, J = 19.5, 9.5 Hz, 1H), 1.83 – 1.77 (m, 1H), 1.22 – 1.18 (m, 1H), 
0.88 (s, 9H), 0.07 (s, 3H), 0.02 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ 208.4, 196.2, 172.5, 
138.3, 135.3, 133.5, 129.6, 128.8, 127.4, 126.3, 125.0, 122.8, 119.4, 113.6, 96.1, 61.6, 50.2, 
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40.1, 34.4, 32.6, 25.9, 18.2, -5.4, -5.4. HRMS (EI) m/z Calcd for [C26H31O4BrSi, M]
+
: 
514.1175; Found: 514.1165. 
Optical Rotation: [α]25D = +28.2 (0.5, CHCl3). 79% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 98:2, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 7.25 min 
for minor isomer, tR = 8.34 min for major isomer). 
 
2.4.8. X-ray Crystallographic Analysis and Determination of 
Configuration of the Products 
The absolute configuration of 2.22g (4S,5R) was assigned by X-ray crystallographic analysis 
of a single crystal of 2.22g (Figure 2-4). The configurations of 2.16a-2.16n, 2.22a-2.22f 
were assigned by analogy. 
(4S,5R)-4-(2-(benzyloxy)ethyl)-5-(2-bromophenyl)-3,4,5,6-tetrahydro-2H-oxepino[3,2-b]i
ndol-2-one  (2.22g) 
after recrystallization, 98% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, 
wavelength = 254 nm, tR = 17.39 min for minor isomer, tR = 
22.99 min for major isomer). 
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Figure 2-4. X-ray structure of 2.22g 
 
Table 2-7. Crystal data and structure refinement for E233A (2.22g) 
Identification code  E233A (2.22g) 
Empirical formula  C27 H24 Br N O3 
Formula weight  490.38 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 10.518(4) Å α= 90°. 
 b = 10.893(4) Å β= 90°. 
 c = 19.602(7) Å γ= 90°. 
Volume 2245.8(14) Å3 
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Z 4 
Density (calculated) 1.450 Mg/m3 
Absorption coefficient 1.860 mm-1 
F(000) 1008 
Crystal size 0.560 x 0.260 x 0.160 mm3 
Theta range for data collection 2.078 to 27.496°. 
Index ranges -13<=h<=13, -8<=k<=14, -25<=l<=24 
Reflections collected 15883 
Independent reflections 5157 [R(int) = 0.0555] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.5737 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5157 / 1 / 293 
Goodness-of-fit on F2 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0368, wR2 = 0.0867 
R indices (all data) R1 = 0.0429, wR2 = 0.0892 
Absolute structure parameter 0.024(8) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.859 and -0.255 e.Å-3 
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Chapter 3 Catalyst-Enabled Diastereodivergent 
aza-Diels-Alder Reaction: Complementarity of 
N-Heterocyclic Carbene and Chiral Amine 
3.1 Introduction 
Structural diversity oriented synthesis of organic compounds plays an important role in 
chemistry and chemical biology. And the efficient generation of these diversities is an 
important goal for organic chemists.
88
 In the field of catalytic methodology development, 
more and more attention has been paid to chemo-, regio-, or diastereodivergent 
transformations from the same starting materials in recent years, which might be realized 
easily just by modulation of the catalyst and reaction conditions and showed its significance 
and prominence in organic synthesis.
89
 In this kind of catalytic selective synthesis, when 
multiple stereocenters are formed, it is undoubtedly more attractive and much more difficult 
to be able to access all the stereoisomers in pure form rather than getting a mixture or simply 
one of the possible relative configurations. Despite all the advances in the field of asymmetric 
organocatalysis, the identification of catalysts that enable such divergent synthesis, remains a 
significant challenge and “requires creativity and insight”.90 Only a few pioneering examples 
of diastereodivergent asymmetric catalysis all realized through the asymmetric 
functionalization of α- or β- positions (relative to the active carbonyl group) have been 
reported. MacMillan group reported the use of two different amine catalysts for the control of 
two stereogenic centers in each step (Scheme 3-1. a)
91
 and recently the simultaneous 
formation of two stereocenters by the act of amine and Iridium co-catalysts working 




 (Scheme 3-1. b) have been elegantly demonstrated by Carreira group. More 
examples from MacMillan, Deng, Melchiorre, Maulide, Carreira, Ye and many other groups 
have been reported in the literature in which the modification of the chiral ligand or catalyst 
structure could also lead to diastereodivergent catalysis.
89a,93
 I present here two different 
catalyst systems (NHC and chiral amine) are used for the Diels-Alder reactions of azadiene 
and aldehyde as an efficient method for diastereodivergent catalysis by giving exquisite 
stereoselectivity and complementary diastereocontrol (Scheme 3-1. c).  
During the past few decades, both chiral amines and carbenes have been developed into 
powerful tool for the synthesis of a diverse range of chiral compounds.
77h,77k,77m,93t,94
 Besides, 
NHCs and amines are widely reported for organocatalytic product-selective catalysis due to 
their facile access to different intermediates. In addition, Aza-Diels Alder reaction with 
excellent level of stereoselectivity
95
 has been reported for the construction of heterocycles by 
using both catalytic systems. While simple aldehydes with enone/azadienes can be catalyzed 
by chiral amines to produce the lactol/hemiaminal as the initial product,
96
 the functionalized 
aldehydes are used in analogous NHC catalysis to generate lactone/lactams 
directly.
31-32,35,37-40,42,44,80b,80e,80h,80k,97
 The choices of diastereocontrol in these two catalyst 
systems, although not compared directly, are complementary in many known systems. 
NHC-catalyzed annulation reactions have been used as a tool in my group to access chemical 
structural diverse compounds for biological screening. Very recently, my group reported the 
use of heterocyclic enones related to a (Scheme 3-1. c) for product-selective catalysis to 
generate either 7-member-ring lactones or spirocyclic heterocycles in high stereoselectivity in 
the presence of different NHC catalysts.
63-65,80f,97b,98
 I want to continue my study of this kind 
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of substrates for the synthesis of both diastereomeric series of N-heterocycles, to further 
enhance the structure diversity of this class of compounds, which has attracted considerable 
attention for their biological activity.
99
 Herein, I present my development of the first example 
of a highly diastereodivergent, asymmetric aza-DA reaction by employing chiral amine and 
NHC catalytic systems. Besides the excellent stereoselectivity, the extreme high level of 
catalytic efficiency in these two catalytic systems also highlights the great potential of this 
chemistry in structural diversity oriented synthesis. 
 
Scheme 3-1. Diastereodivergeny enabled by dual catalytic system 
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3.2 Results and Discussion 
3.2.1 Optimization of cis-Selective Aza-DA Reaction 
Experimentally, I initiated the NHC catalyzed reactions of azadiene 3.1a with 
α-chloroaldehyde 3.2a by examining the efficiency of different NHC catalysts; representative 
results are listed in Table 3-1. It all took less than 10 minutes for the formation of 3.3a in 
excellent yield as a single cis-isomer in the presence of various azolium salts including A, B 
and C at 10 mol% loading with NEt3 as the base (entries 1-3). However, catalyst A and B 
showed superior results (>99% ee) than C (84% ee, entry 3) in terms of the enantioselectivity. 
I tried to test the efficiency of this reaction by lowering the catalyst loading of A. The 
reaction efficiency was proved to be extremely high. I could find that when catalyst A was 
reduced from 5% to 1% (entries 4-6), all the results kept the same (dr>20:1, ee>99%, yield 
96%) except for the reaction time, which was prolonged from 10 minutes to 4 hours. After 
screening of various solvents, it was found that the reaction was similarly efficient and gave 
similar selectivity in a range of solvents (entries 6-9). Finally, I chose the condition in entry 6 
for the substrate scope of this catalytic system, because the use of DCM as the solvent gave 
us consistently better results for all the substrates examined (Scheme 3-2). 
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1 A (10) CH2Cl2 <10 min >20:1 96 >99 
2 B (10) CH2Cl2 <10 min >20:1 95 >99 
3 C (10) CH2Cl2 <10 min >20:1 95 84 
4 A (5) CH2Cl2 20 min >20:1 96 >99 
5 A (2) CH2Cl2 90 min >20:1 96 >99 
6 A (1) CH2Cl2 4 h >20:1 96 >99 
7 A (1) THF 5 h >20:1 95 >99 
8 A (1) Et2O 5 h >20:1 93 >99 
9 A (1) toluene 5 h >20:1 95 >99 
[a]Unless noted otherwise, 3.1a (0.05 mmol), 3.2a, azolium salt and NEt3 were allowed to stir in solvent (1.0 
mL) at 23 °C for the give period of time. [b] Determined by 1H NMR analysis of the crude reaction mixture. [c] 
Isolated yield. [d] Determined by HPLC. 
 
3.2.2 Substrate Scope of cis-Selective Aza-DA Reaction 
The substrate scope of this catalytic system turned out to be rather broad. The easily 
accessible and stable N-tosyl azadienes 3.1 bearing ortho-, meta- or para-substituents of both 
electron-poor and electron-rich characters at the aryl rings could could proceed very well to 
form the corresponding dihydropyridinones (3.3a-3.3j) in similarly excellent diastereo- and 
enantioselectivity. Remarkably, the sterically challenging ortho-substituted substrates could 
participate in this reaction with similar reactivity to produce 3.3f-3.3g in high yields. 
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Scheme 3-2. Scope of NHC-catalyzed cis-selective Diels-Alder
a 
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[a]Unless noted otherwise, 3.1 (0.10 mmol), 3.2, azolium salt and NEt3 were added to CH2Cl2 (1.0 mL) and 
allowed to stir at 23 °C for 6 h. 
In addition, various α-chloroaldehydes bearing different linear alkyl substituents could also 
be tolerated well in this reaction, giving uniformly excellent results (3.3k-3.3m). Compared 
to the previously reported NHC-catalyzed aza-DA reactions,
31-32,35,37-40,42,44,80b,80e,80h,80k,97
 the 
greatly improved efficiency in my system may result from the driving force of aromatization 
in benzofuran formation.
63-65,80f,97b,98
 The relative and absolute configuration of 3.3a was 
unambiguously assigned by single-crystal X-ray diffraction analysis. Considering a similar 
reaction mechanism for the formation of 3.3, and in connection with the same NMR 
characters for all the products, the other dihydropyridinones 3.3 were assigned to have the 
same relative and absolute configuration. 
 
3.2.3 Reduction of the Lactam 
Scheme 3-3. Access to cis-tetrahydropyridine 
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Many further transformations can be achieved from the resulting multi-substituted 
dihydropyridinones. For example, the lactam moiety in 3.3 can be reduced to yield the 
corresponding cis-tetrahydropyridine 3.4 in good yields without any erosion of diastereo- and 
enantiopurity (Scheme 3-3). 
 
3.2.4 Optimization of trans-Selective Aza-DA Reaction 
Trying to access the trans-series of the benzofuran-fused heterocycles, I turned my attention 
to examine the reaction between 3.1a and butyraldehyde (3.5a) by using the commercially 
available α,α-diphenylprolinoltrimethylsilyl ether D100 as the catalyst with benzoic acid at 20 
mol% loading, which is a typical additive for enamine catalysis (Table 3-2). The catalyzed 
aza-DA reaction showed very high reactivity and reached completion within less than one 
hour. The desired tetrahydropyridine 3.6a was produced in a high yield of 97% with 93% ee 
by reduction of the hemiaminal moiety with Et3SiH/BF3•Et2O in DCM at ambient 
temperature (entry 1). The aza-DA reaction was accelerated by the addition of water; higher 
selectivity was also achieved by using a mixed solvent of DCM and H2O (10:1) (entry 2). 
This is consistent with previous results that the water plays an important role for the 
hydrolysis of the intermediate to regenerate the catalyst and thus facilitate catalytic turnover 
in chiral amine-catalyzed aza-DA reactions.
96
 I continue to investigate the popular analogous 
catalysts E-G. It showed slightly lower catalytic activity with longer time to complete the 
reaction by using the bulkier silyl ethers E, although led to similar enantioselectivity (entry 3). 
It took even longer time for the reaction to reach completion, giving similar enantioselectivity 
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and yield when the secondary amines F and G with strong electron-withdrawing substituents 
on the aryl rings were used (entries 4 and 5). In terms of catalytic activity, catalyst D was 
chosen as the optimal catalyst for solvent screening. Various commonly used solvents were 
examined next (entries 6-9). While all the solvents led to similarly excellent yield and 
enantioselectivity, Toluene showed the highest reaction rate and turned out to be the best 
choice. Then I tried the reaction with reduced catalyst loading from 10% to 5%, 2% and 1% 
respectively (entries 10-13). To my delight, the reactivity of this catalytic system was so high 
that the reaction could be completed in a few hours even with 1 mol% catalyst loading (entry 
13). Similar to the reactions shown in Scheme 3-2, it is believed that the strong driving force 
of aromatization of the starting material led to high efficiency for the aza-DA reaction. With 
the optimal reaction conditions in hand, I examined the substrate scope of this trans-selective 
aza-DA reaction. Various azadienes 3.1 were tested with aldehydes 5 at room temperature in 
the presence of catalyst D (1 mol%) and additive benzoic acid (1 mol%) in a mixture solvent 
of toluene and H2O (10:1), followed by reduction using Et3SiH/BF3•Et2O to generate the 
tetrahydropyridines 3.6.  
 
Table 3-2. Optimization of trans-aza-DA of 3.1a and 3.5a
a
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 D (20) CH2Cl2 1 > 20:1 97 93 
2 D (20) CH2Cl2 1 > 20:1 96 >99 
3 E (20) CH2Cl2 1.5 > 20:1 95 >99 
4 F (20) CH2Cl2 24 > 20:1 96 >99 
5 G (20) CH2Cl2 72 > 20:1 96 >99 
6 D (20) CH3CN 0.5 > 20:1 96 >99 
7 D (20) THF 2 > 20:1 95 >99 
8 D (20) dioxane 2 > 20:1 97 >99 
9 D (20) toluene 0.5 > 20:1 95 >99 
10 D (10) toluene 1 > 20:1 97 >99 
11 D (5) toluene 1.5 > 20:1 96 >99 
12 D (2) toluene 3 > 20:1 96 >99 
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13 D (1) toluene 4 > 20:1 93 >99 
[a]Reaction conditions: 3.1a (0.05 mmol), 3.5a (0.075 mmol) and amine catalyst and benzoic acid were allowed 
to stir in the listed solvent (0.5 mL) and H2O (0.05 mL) at ambient temp. [b] Determined by HPLC (Chirapak 
Daicel IC).  [c] Isolated yield. [d]without water. 
3.2.5 Substrate Scope of trans-Selective Aza-DA Reaction 
A wide range of ortho-, meta- or para-substituents at the aryl rings of ketimine 3.1 could react 
well with butyraldehyde, all giving excellent diastereo- and enantioselectivity, although a 
little lower yield was obtained for the ortho-bromo-substituted product 3.6g, probably due to 
steric hindrance (Scheme 3-4).  
Scheme 3-4. Scope of chiral amine-catalyzed trans-selective Diels-Alder
a
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[a]Unless noted otherwise, the reactions of 3.1 (0.15 mmol) and 3.5 (0.225 mmol) in the presence of 1 mol% of 
D and PhCOOH were allowed to stir in toluene (1.5 mL) and H2O (0.15 mL) (10:1) at ambient temp. The 
hemiaminal was then reduced with Et3SiH/BF3•Et2O in CH2Cl2 at ambient temp. 
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Other aldehydes including the linear and branched aliphatic and benzylic ones could all 
proceed smoothly with 3.1 in the aza-DA reaction to form 3.6i-3.6l in similarly excellent 
yield and stereoselectivity. The relative and absolute configuration of 3.6b was 
unambiguously assigned by single-crystal X-ray diffraction analysis. Considering a similar 
reaction mechanism and in connection with the same NMR characters for all the products 3.6, 
the configuration of all other products was assigned to be the same by analogy. 
It is important to note that the products shown in Schemes 3-3 and 3-4 are the two 
diastereomeric series of benzofuran-fused tetrahydropyridines. Thus, it’s possible for us to 
obtain all the possible isomers of this class of compounds by using either readily available 
NHC or chiral amine catalyst. The high level of catalytic efficiency and stereoselectivity of 
this method shows great potential in asymmetric synthesis. 
 
3.2.6 Proposed Mechanism 
The diastereodivergency of my catalytic systems could be explained in different reaction 
pathways shown in Scheme 3-5. Based on previous literatures of chiral NHC and amine 
catalysis, the cis-series of the products could be generated from the NHC-containing (Z)-enol 
3-I followed by a concerted [4+2] cycloaddition through TS 3-A. In the amine catalysis, 
enamine 3-II will go through TS 3-B to give the trans-products. 
 
Scheme 3-5. Rationale for divergent reactivity 
a. NHC catalyzed pathway 




b. amine catalyzed pathway 
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3.3 Conclusions 
In conclusion, highly efficient catalytic aza-DA reactions have been developed to access 
either diastereomeric series of the benzofuran-fused lactams and tetrahydropyridines. It is 
presented for the first time that the complementarity of chiral amine and NHC catalysts has 
made it possible to achieve such diastereodivergent and highly stereoselective 
transformations. It is believed that it should be a general strategy for substrates beyond the 
azadienes included in this paper. Further applications of this kind of reactions are currently 
underway. 
 
3.4 Experimental Section 
3.4.1 General Information 
Thin layer chromatography (TLC) was performed on Merck pre-coated TLC plates (Merck 
60 F254), and compounds were visualized with a UV light at 254nm. Further visualization 
was achieved by staining with iodine, or potassium permanganate solution followed by 
heating using a heat gun. Flash chromatography separations were performed on Merck 60 




C NMR spectra were recorded on a Bruker 
ACF300 (300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0) or tetramethylsilane (TMS δ 0.00) 
was used as a reference. Data are reported as follows: chemical shift, multiplicity (s = singlet, 
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d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants (Hz) and 
integration.  High resolution mass spectra (HRMS) were obtained from National University 
of Singapore mass spectral facility. Optical rotations were recorded on an mrc AP81 
automatic polarimeter.  Enantiomeric excesses (ee) were determined by HPLC analysis on 
Agilent HPLC units, including the following instruments: pump, LC-20AD; detector, 
SPD-20A; column, Chiralpak IC and ID.  
All reactions were carried out under nitrogen atmosphere. All solvents were purified and 
dried according to standard methods prior to use. NHC precursors A, B, and C were prepared 
according to literatures.
31,86
 The chiral amine catalysts if not commercially available were 
also synthesized according to the literature procedures.
100a,b,101
 
3.4.2 General Procedure for Synthesis of Substrates 
 
The substrates 3.1 were synthesized according to modified previous reported protocols
102
: 
4-methylbenzenesulfonamide (513 mg, 3.0 mmol) and heterocyclic enones
98a
 (3 mmol) were 
added in a round bottom flask under N2 in Toluene (40 mL), cooled to 0°C, were successively 
added Et3N (0.84 mL, 6.0 mmol) and TiCl4 (1.0 M in Toluene, 3.0 mL, 3.0 mmol). The 
reaction mixture was heated for reflux under nitrogen overnight. The solution was then 
cooled to room temperature, quenched with water (100 mL), and extracted with DCM (3 × 30 
mL). The combined organic phase was dried over MgSO4 and concentrated. The residue was 
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purified by flash chromatography on silica gel to afford the substrates 3.1. 





H NMR (500 MHz, CDCl3): δ 8.78 (d, J = 8.1 Hz, 1H), 
8.00 (d, J = 8.2 Hz, 2H), 7.89 (d, J = 7.0 Hz, 2H), 7.69 (ddd, J = 8.5, 7.2, 
1.4 Hz, 1H), 7.47 – 7.35 (m, 5H), 7.33 (d, J = 8.3 Hz, 1H), 7.29 (t, J = 
7.7 Hz, 1H), 7.12 (s, 1H), 2.48 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 165.1, 164.8, 149.6, 
143.4, 139.0, 137.6, 132.4, 131.7, 131.1, 130.2, 129.4, 128.9, 127.0, 123.8, 118.3, 115.7, 
112.3, 21.6. HRMS (ESI) m/z Calcd for [C22H18NO3S, M+H]
+






H NMR (500 MHz, CDCl3): δ 8.77 (d, J = 8.0 Hz, 
1H), 7.99 (d, J = 8.2 Hz, 2H), 7.73 (d, J = 8.6 Hz, 2H), 7.71 – 7.66 
(m, 1H), 7.55 (d, J = 8.6 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 7.33 – 
7.27 (m, 2H), 7.01 (s, 1H), 2.47 (s, 3H). 
13
C NMR (126 MHz, 
CDCl3): δ 164.9, 164.6, 149.9, 143.5, 138.8, 137.7, 132.8, 132.2, 131.3, 131.1, 129.5, 127.0, 
124.7, 123.9, 118.2, 114.0, 112.3, 21.6.  HRMS (ESI) m/z Calcd for [C22H17BrNO3S, 
M+H]
+
: 454.0107; Found: 454.0115.  
 






H NMR (500 MHz, CDCl3): δ 8.77 (d, J = 8.1 Hz, 
1H), 7.99 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 8.6 Hz, 2H), 7.68 (ddd, J = 
8.5, 7.3, 1.4 Hz, 1H), 7.43 – 7.35 (m, 4H), 7.32 (d, J = 3.9 Hz, 1H), 
7.29 (d, J = 3.7 Hz, 1H), 7.03 (s, 1H), 2.47 (s, 3H). 
13
C NMR (126 
MHz, CDCl3): δ 164.9, 164.6, 149.8, 143.4, 138.9, 137.7, 136.2, 132.7, 131.1, 130.9, 129.5, 
129.2, 127.0, 123.9, 118.2, 114.0, 112.3, 21.6. HRMS (ESI) m/z Calcd for [C22H17ClNO3S, 
M+H]
+






H NMR (500 MHz, CDCl3): δ 8.78 (d, J = 8.1 Hz, 1H), 
8.00 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 7.9 Hz, 2H), 7.67 (ddd, J = 8.5, 
7.2, 1.4 Hz, 1H), 7.37 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.3 Hz, 1H), 
7.28 (d, J = 7.8 Hz, 1H), 7.25 (d, J = 8.0 Hz, 2H), 7.12 (s, 1H), 2.47 (s, 
3H), 2.40 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 165.1, 164.7, 149.2, 143.2, 141.0, 139.1, 
137.4, 131.8, 131.0, 129.7, 129.7, 129.4, 127.0, 123.7, 118.5, 116.2, 112.3, 21.7, 21.6. 
HRMS (ESI) m/z Calcd for [C23H20NO3S, M+H]
+








H NMR (500 MHz, CDCl3): δ 8.77 (d, J = 8.0 Hz, 
1H), 8.00 (d, J = 8.3 Hz, 2H), 7.86 (d, J = 8.9 Hz, 2H), 7.65 (ddd, J = 
8.4, 7.2, 1.4 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 7.28 – 7.23 (m, 1H), 
7.12 (s, 1H), 6.95 (d, J = 9.0 Hz, 2H), 3.85 (s, 3H), 2.46 (s, 3H). 
13
C 
NMR (126 MHz, CDCl3): δ 164.8, 164.4, 161.5, 148.3, 143.1, 139.2, 137.1, 133.8, 130.8, 
129.4, 126.9, 125.2, 123.5, 118.6, 116.5, 114.5, 112.2, 55.4, 21.6. HRMS (ESI) m/z Calcd for 
[C23H20NO4S, M+H]
+






H NMR (500 MHz, CDCl3): δ 8.80 (d, J = 8.0 Hz, 
1H), 8.02 (d, J = 8.2 Hz, 2H), 7.96 (d, J = 8.5 Hz, 2H), 7.71 – 7.61 
(m, 5H), 7.47 (t, J = 7.7 Hz, 2H), 7.39 (dd, J = 7.8, 2.2 Hz, 3H), 
7.34 (d, J = 8.3 Hz, 1H), 7.29 (ddd, J = 8.2, 7.3, 1.0 Hz, 1H), 7.15 
(s, 1H), 2.48 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 165.0, 
164.7, 149.7, 143.3, 142.8, 140.0, 139.0, 137.5, 132.2, 131.4, 131.0, 129.4, 128.9, 128.0, 
127.5, 127.0, 127.0, 123.8, 118.4, 115.4, 112.3, 21.6. HRMS (ESI) m/z Calcd for 
[C28H22NO3S, M+H]
+








H NMR (500 MHz, CDCl3): δ 8.78 (d, J = 8.0 Hz, 
1H), 8.30 (dd, J = 7.9, 1.6 Hz, 1H), 8.02 (d, J = 8.3 Hz, 2H), 7.68 (t, 
J = 7.8 Hz, 1H), 7.63 (dd, J = 8.1, 1.2 Hz, 1H), 7.56 (s, 1H), 7.42 (t, 
J = 7.6 Hz, 1H), 7.38 (d, J = 8.0 Hz, 2H), 7.30 (dt, J = 7.6, 3.4 Hz, 
2H), 7.22 (td, J = 7.7, 1.7 Hz, 1H), 2.47 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 164.9, 164.8, 
150.5, 143.4, 138.9, 137.7, 133.4, 132.4, 132.1, 131.2, 131.0, 129.4, 127.7, 127.0, 126.4, 
124.0, 118.2, 113.0, 112.3, 21.6. HRMS (ESI) m/z Calcd for [C22H17BrNO3S, M+H]
+
: 






H NMR (500 MHz, CDCl3): δ 8.79 (d, J = 7.7 Hz, 
1H), 8.24 (dd, J = 7.4, 1.8 Hz, 1H), 8.03 (d, J = 8.3 Hz, 2H), 7.70 
(ddd, J = 8.5, 7.3, 1.4 Hz, 1H), 7.49 – 7.43 (m, 1H), 7.40 (d, J = 8.0 
Hz, 2H), 7.34 – 7.30 (m, 3H), 7.26 (d, J = 7.3 Hz, 1H), 2.50 (s, 3H), 
2.46 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 165.2, 164.9, 143.3, 139.2, 139.1, 137.5, 131.3, 
131.0, 130.7, 130.2, 129.4, 127.1, 126.9, 126.4, 123.7, 112.3, 21.6, 20.1. HRMS (ESI) m/z 
Calcd for [C23H20NO3S, M+H]
+








H NMR (500 MHz, CDCl3): δ 8.78 (d, J = 8.1 Hz, 
1H), 7.99 (d, J = 8.3 Hz, 2H), 7.90 (s, 1H), 7.77 – 7.65 (m, 2H), 7.38 
(d, J = 7.9 Hz, 2H), 7.37 – 7.33 (m, 3H), 7.30 (td, J = 7.7, 7.3, 1.0 
Hz, 1H), 7.00 (s, 1H), 2.48 (s, 3H). 
13
C NMR (126 MHz, CDCl3): 
δ 164.9, 164.8, 150.3, 143.5, 138.7, 137.8, 134.8, 134.1, 131.2, 131.0, 130.0, 130.0, 129.6, 
129.5, 127.1, 124.0, 118.1, 113.4, 112.4, 21.6. HRMS (ESI) m/z Calcd for [C22H17ClNO3S, 
M+H]
+






H NMR (500 MHz, CDCl3): δ 8.78 (d, J = 
8.2 Hz, 1H), 8.00 (d, J = 8.3 Hz, 2H), 7.74 (d, J = 7.9 Hz, 1H), 
7.72 – 7.64 (m, 2H), 7.38 (d, J = 8.2 Hz, 2H), 7.36 – 7.31 (m, 
2H), 7.29 (t, J = 7.7 Hz, 1H), 7.22 (d, J = 7.7 Hz, 1H), 7.10 (s, 
1H), 2.48 (s, 3H), 2.40 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 165.1, 164.8, 149.5, 143.3, 
139.1, 138.6, 137.5, 132.3, 131.2, 131.1, 129.4, 128.9, 128.8, 127.0, 123.7, 118.4, 116.0, 
112.3, 21.6, 21.4. HRMS (ESI) m/z Calcd for [C23H20NO3S, M+H]
+









H NMR (500 MHz, CDCl3): δ 8.81 (d, J = 8.2 Hz, 
1H), 8.30 (s, 1H), 8.05 (dd, J = 21.7, 8.4 Hz, 3H), 7.93 – 7.78 (m, 3H), 
7.71 (t, J = 7.8 Hz, 1H), 7.58 – 7.48 (m, 2H), 7.39 (dd, J = 8.2, 4.9 Hz, 
3H), 7.33 – 7.26 (m, 2H), 2.49 (s, 3H) 13C NMR (126 MHz, CDCl3): 
δ 165.0, 164.8, 149.8, 143.3, 139.1, 137.5, 133.9, 133.3, 132.8, 
131.1, 130.1, 129.5, 128.8, 128.6, 127.8, 127.7, 127.6, 127.1, 126.7, 123.8, 118.4, 115.9, 
112.3, 21.6. HRMS (ESI) m/z Calcd for [C26H20NO3S, M+H]
+
: 426.1158; Found: 426.1167.  
3.4.4 General Procedure for NHC-Catalyzed cis-Aza-DA Reaction 
 
General procedure: Substrates 3.1(0.10 mmol), triazolium salt A (0.4 mg, 0.001 mmol) 
were added in a 4 mL vial. Then the mixture was taken into glovebox, where anhydrous 
DCM (1.0 mL), α-chloroaldehydes 3.2 (0.15mmol), NEt3 (21 μL, 0.15 mmol) were added 
using a micropipette. The reaction mixture was taken outside the glovebox, and the reaction 
mixture was allowed to stir at ambient temperature for 6 hr. The crude reaction mixture was 
directly purified by silica gel column chromatography with hexanes/ethyl acetate (5:1) as 
eluent to afford the desired product 3.3. 
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Colorless solid, 96% yield, dr > 20:1. 
1
H NMR (500 MHz, CDCl3): δ 
8.21 (dd, J = 7.0, 2.5 Hz, 1H), 8.06 (d, J = 8.3 Hz, 2H), 7.40 (dd, J = 7.7, 
5.8 Hz, 3H), 7.37 – 7.30 (m, 2H), 7.28 – 7.18 (m, 4H), 7.07 (t, J = 7.7 Hz, 2H), 6.95 (d, J = 6.7 
Hz, 2H), 6.71 (d, J = 7.2 Hz, 2H), 4.01 (d, J = 7.0 Hz, 1H), 3.40 (ddd, J = 10.7, 6.9, 4.1 Hz, 1H), 
3.31 (dd, J = 14.6, 4.1 Hz, 1H), 2.54 (s, 3H), 2.35 (dd, J = 14.6, 10.4 Hz, 1H).
 13
C NMR (126 
MHz, CDCl3): δ 171.4, 153.9, 147.8, 145.4, 137.8, 134.8, 134.6, 129.9, 129.4, 128.9, 128.7, 
128.6, 128.2, 127.7, 126.6, 124.9, 123.3, 123.0, 122.7, 117.9, 111.3, 49.5, 39.8, 32.1, 21.7. 
HRMS (ESI) m/z Calcd for [C31H25NNaO4S, M+Na]
+
: 530.1397; Found: 530.1400.  
Optical Rotation: [α]23D = +11.1 (1.0, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 18.67 




Pale yellow viscous oil, 95% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.25 – 8.12 (m, 1H), 8.01 (d, J = 8.3 Hz, 2H), 7.44 – 7.29 
(m, 5H), 7.24 (dd, J = 13.0, 5.5 Hz, 3H), 7.18 – 7.12 (m, 2H), 6.92 (d, 
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J = 8.5 Hz, 2H), 6.56 (d, J = 8.5 Hz, 2H), 3.94 (d, J = 6.7 Hz, 1H), 3.38 (ddd, J = 10.4, 6.6, 3.8 
Hz, 1H), 3.30 (dd, J = 14.8, 4.3 Hz, 1H), 2.55 (s, 3H), 2.32 (dd, J = 14.6, 10.4 Hz, 1H).
 13
C 
NMR (126 MHz, CDCl3): δ 171.3, 153.9, 147.3, 145.7, 137.5, 134.5, 133.9, 131.9, 129.9, 
129.8, 129.5, 128.8, 128.7, 126.8, 125.1, 123.5, 123.0, 122.7, 121.7, 118.2, 111.4, 49.3, 39.1, 
32.2, 21.8. HRMS (ESI) m/z Calcd for [C31H24BrNNaO4S, M+Na]
+
: 608.0502; Found: 
608.0506.  
Optical Rotation: [α]23D = +85.9 (0.8, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 12.40 




Pale yellow viscous oil, 95% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.30 – 8.17 (m, 1H), 8.05 (d, J = 8.3 Hz, 2H), 7.48 – 7.33 
(m, 5H), 7.31 – 7.18 (m, 3H), 7.05 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 
6.7 Hz, 2H), 6.66 (d, J = 8.5 Hz, 2H), 4.00 (d, J = 6.8 Hz, 1H), 3.42 
(ddd, J = 10.7, 6.8, 4.2 Hz, 1H), 3.33 (dd, J = 14.8, 4.2 Hz, 1H), 2.58 (s, 3H), 2.36 (dd, J = 14.7, 
10.5 Hz, 1H).
 13
C NMR (126 MHz, CDCl3): δ 171.3, 153.9, 147.4, 145.6, 137.5, 134.6, 133.6, 
133.4, 129.9, 129.5, 128.9, 128.8, 128.7, 126.8, 125.1, 123.4, 123.0, 122.6, 118.1, 111.4, 49.3, 
39.0, 32.2, 21.7. HRMS (ESI) m/z Calcd for [C31H24ClNNaO4S, M+Na]
+
: 564.1007; Found: 
564.1012.  
Optical Rotation: [α]23D = +88.9 (0.6, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
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column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.75 
min for major isomer, tR = 14.17 min for minor isomer). 
 
(3S,4S)-3-benzyl-4-p-tolyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3d). 
Pale yellow viscous oil, 95% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.21 (dd, J = 7.4, 1.9 Hz, 1H), 8.07 (d, J = 8.1 Hz, 2H), 7.44 
– 7.30 (m, 5H), 7.30 – 7.20 (m, 4H), 6.97 (d, J = 6.9 Hz, 2H), 6.88 (d, 
J = 7.8 Hz, 2H), 6.60 (d, J = 7.8 Hz, 2H), 3.98 (d, J = 6.9 Hz, 1H), 3.38 
(ddd, J = 10.7, 6.9, 4.0 Hz, 1H), 3.30 (dd, J = 14.6, 4.1 Hz, 1H), 2.56 (s, 3H), 2.36 (dd, J = 14.6, 
10.4 Hz, 1H), 2.32 (s, 3H).
 13
C NMR (126 MHz, CDCl3): δ 171.5, 153.9, 148.2, 145.4, 138.0, 
137.4, 134.7, 131.8, 129.9, 129.4, 129.4, 128.9, 128.6, 128.1, 126.6, 124.8, 123.3, 123.0, 
122.8, 117.8, 111.4, 49.7, 39.5, 32.1, 21.8, 21.1. HRMS (ESI) m/z Calcd for [C32H27NNaO4S, 
M+Na]
+
: 544.1553; Found: 544.1554.  
Optical Rotation: [α]23D = +66.8 (0.3, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 13.04 




Pale yellow viscous oil, 76% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 8.11 (d, J = 7.4 Hz, 1H), 7.98 (d, J = 8.1 Hz, 2H), 
7.43 (d, J = 7.9 Hz, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.27 (ddd, J = 
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19.9, 14.2, 7.3 Hz, 6H), 7.20 – 7.10 (m, 6H), 6.89 (d, J = 7.4 Hz, 2H), 6.67 (d, J = 8.0 Hz, 2H), 
3.95 (d, J = 6.8 Hz, 1H), 3.32 (ddd, J = 10.5, 6.7, 4.2 Hz, 1H), 3.24 (dd, J = 14.7, 3.8 Hz, 1H), 
2.41 (s, 3H), 2.31 (dd, J = 14.6, 10.5 Hz, 1H).
 13
C NMR (126 MHz, CDCl3): δ 171.5, 153.9, 
147.9, 145.4, 140.5, 140.3, 137.9, 134.7, 133.8, 130.0, 129.5, 128.9, 128.8, 128.6, 128.6, 
127.5, 127.4, 126.8, 126.7, 124.9, 123.4, 123.0, 122.8, 118.0, 111.4, 49.6, 39.4, 32.2, 21.7. 
HRMS (ESI) m/z Calcd for [C37H29NNaO4S, M+Na]
+
: 606.1710; Found: 606.1713.  
Optical Rotation: [α]24D = +74.8 (0.6, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 17.92 




Pale yellow viscous oil, 82% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.14 (dd, J = 6.2, 3.3 Hz, 1H), 8.04 (d, J = 8.0 Hz, 2H), 7.58 
(d, J = 8.0 Hz, 1H), 7.40 (d, J = 8.4 Hz, 3H), 7.32 (dd, J = 6.2, 3.3 Hz, 
2H), 7.25 – 7.16 (m, 3H), 7.12 – 7.04 (m, 1H), 6.85 (d, J = 6.7 Hz, 2H), 
6.78 (t, J = 7.6 Hz, 1H), 6.37 (dd, J = 7.8, 1.6 Hz, 1H), 4.74 (d, J = 7.3 Hz, 1H), 3.39 (ddd, J = 
9.7, 7.3, 4.9 Hz, 1H), 3.26 (dd, J = 14.5, 4.9 Hz, 1H), 2.54 (s, 3H), 2.42 (dd, J = 14.3, 9.4 Hz, 
1H).
 13
C NMR (126 MHz, CDCl3): δ 171.5, 153.9, 147.0, 145.4, 137.6, 134.9, 134.6, 133.6, 
129.9, 129.5, 129.1, 128.8, 128.7, 128.2, 127.8, 126.6, 125.5, 125.1, 123.3, 122.8, 122.5, 
118.2, 111.5, 49.5, 38.2, 32.3, 21.8. HRMS (ESI) m/z Calcd for [C31H24BrNNaO4S, M+Na]
+
: 
608.0502; Found: 608.0504.  
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Optical Rotation: [α]22D = +97.1 (0.4, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 17.22 
min for major isomer, tR = 18.97 min for minor isomer). 
 
(3S,4S)-3-benzyl-4-o-tolyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3g). 
Pale yellow viscous oil, 98% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.14 (dd, J = 6.4, 2.7 Hz, 1H), 8.01 (d, J = 8.3 Hz, 2H), 7.34 
(dd, J = 47.2, 7.3 Hz, 6H), 7.21 – 7.16 (m, 3H), 7.11 (dt, J = 14.6, 7.2 
Hz, 2H), 6.73 (dd, J = 6.3, 2.7 Hz, 2H), 6.62 (t, J = 7.3 Hz, 1H), 6.14 
(d, J = 7.7 Hz, 1H), 4.17 (d, J = 7.3 Hz, 1H), 3.40 (ddd, J = 11.1, 7.2, 4.2 Hz, 1H), 3.34 (dd, J = 
14.2, 4.1 Hz, 1H), 2.54 (s, 3H), 2.42 (dd, J = 14.2, 11.1 Hz, 1H), 2.10 (s, 3H).
 13
C NMR (126 
MHz, CDCl3): δ 171.9, 153.7, 148.1, 145.4, 137.7, 137.0, 134.5, 133.7, 130.9, 130.0, 129.4, 
128.7, 128.6, 127.4, 126.6, 126.4, 126.3, 124.8, 123.2, 122.9, 122.7, 117.6, 111.2, 48.8, 34.5, 
32.3, 21.8, 19.7. HRMS (ESI) m/z Calcd for [C32H27NNaO4S, M+Na]
+
: 544.1553; Found: 
544.1554.  
Optical Rotation: [α]24D = +20.8 (0.4, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.97 
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Pale yellow viscous oil, 94% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 8.13 – 8.05 (m, 1H), 7.95 (d, J = 8.4 Hz, 2H), 
7.39 – 7.21 (m, 6H), 7.20 – 7.08 (m, 5H), 6.84 (ddd, J = 9.2, 8.6, 
4.8 Hz, 4H), 6.44 (d, J = 7.9 Hz, 1H), 3.89 (d, J = 6.9 Hz, 1H), 3.31 
(ddd, J = 10.8, 6.9, 4.2 Hz, 1H), 3.24 (dd, J = 14.7, 4.1 Hz, 1H), 2.42 (s, 3H), 2.33 – 2.20 (m, 
1H).
 13
C NMR (126 MHz, CDCl3): δ 171.07, 153.96, 146.84, 145.56, 137.48, 136.95, 134.82, 
134.68, 130.08, 129.68, 129.56, 128.93, 128.83, 128.70, 128.06, 126.82, 125.81, 125.13, 
123.43, 123.00, 122.53, 118.25, 111.44, 49.20, 39.33, 32.14, 21.79. HRMS (ESI) m/z Calcd 
for [C31H24ClNNaO4S, M+Na]
+
: 564.1007; Found: 564.1008.  
Optical Rotation: [α]23D = +7.5 (0.7, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.94 
min for major isomer, tR = 16.35 min for minor isomer). 
 
(3S,4S)-3-benzyl-4-m-tolyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3i). 
Pale yellow viscous oil, 78% yield, dr > 20:1. 
1
H NMR (500 
MHz, CDCl3): δ 8.11 – 8.06 (m, 1H), 7.97 (d, J = 8.4 Hz, 2H), 
7.32 – 7.26 (m, 3H), 7.26 – 7.19 (m, 3H), 7.18 – 7.09 (m, 4H), 
6.94 (d, J = 7.2 Hz, 1H), 6.85 (d, J = 6.6 Hz, 2H), 6.80 (t, J = 
7.6 Hz, 1H), 6.71 (s, 1H), 6.31 (d, J = 8.2 Hz, 1H), 3.88 (d, J = 6.9 Hz, 1H), 3.28 (ddd, J = 
10.6, 6.9, 4.1 Hz, 1H), 3.21 (dd, J = 14.6, 4.1 Hz, 1H), 2.41 (s, 3H), 2.28 (dd, J = 14.7, 10.4 
Hz, 1H), 2.15 (s, 3H).
 13
C NMR (126 MHz, CDCl3): δ 171.5, 153.9, 147.9, 145.3, 138.7, 
138.0, 135.1, 134.8, 129.7, 129.5, 129.4, 128.9, 128.6, 128.5, 128.5, 126.6, 124.8, 124.7, 
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123.3, 122.8, 122.7, 117.8, 111.4, 49.5, 39.8, 32.1, 21.7, 21.3. HRMS (ESI) m/z Calcd for 
[C32H27NNaO4S, M+Na]
+
: 544.1553; Found: 544.1564.  
Optical Rotation: [α]24D = +7.5 (0.6, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.11 




Pale yellow viscous oil, 80% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.22 – 8.16 (m, 1H), 8.05 (d, J = 8.4 Hz, 2H), 7.82 – 7.73 
(m, 1H), 7.59 – 7.51 (m, 2H), 7.50 – 7.44 (m, 2H), 7.41 – 7.38 (m, 1H), 
7.36 – 7.30 (m, 5H), 7.25 – 7.22 (m, 3H), 6.95 – 6.88 (m, 2H), 6.84 
(dd, J = 8.5, 2.0 Hz, 1H), 4.18 (d, J = 6.9 Hz, 1H), 3.46 (ddd, J = 10.8, 
6.9, 4.1 Hz, 1H), 3.35 (dd, J = 14.7, 4.1 Hz, 1H), 2.53 (s, 3H), 2.44 (dd, J = 14.7, 10.5 Hz, 1H).
 
13
C NMR (126 MHz, CDCl3): δ 171.6, 154.0, 147.8, 145.4, 137.9, 135.1, 133.2, 132.6, 132.4, 
129.8, 129.5, 128.9, 128.7, 128.6, 128.0, 127.5, 127.5, 126.7, 126.3, 126.3, 125.6, 124.9, 
123.4, 122.9, 122.7, 118.0, 111.4, 49.6, 39.8, 32.3, 21.8. HRMS (ESI) m/z Calcd for 
[C35H27NNaO4S, M+Na]
+
: 580.1553; Found: 580.1557.  
Optical Rotation: [α]23D = +61.8 (0.6, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 17.32 
min for major isomer, tR = 28.90 min for minor isomer). 
 
PHD DISSERTATION 2016                                                                   WANG MIN 
117 
(3S,4S)-3-hexyl-4-phenyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3k). 
Pale yellow viscous oil, 98% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.26 – 8.18 (m, 1H), 8.01 (d, J = 8.1 Hz, 2H), 7.46 – 7.40 (m, 
1H), 7.38 – 7.31 (m, 4H), 7.17 (t, J = 7.4 Hz, 1H), 7.03 (t, J = 7.6 Hz, 
2H), 6.78 (d, J = 7.6 Hz, 2H), 4.21 (d, J = 7.0 Hz, 1H), 2.98 (td, J = 7.7, 
5.8 Hz, 1H), 2.50 (s, 3H), 1.74 (td, J = 13.7, 7.9 Hz, 2H), 1.24 – 1.14 (m, 8H), 0.83 (t, J = 6.9 Hz, 
3H).
 13
C NMR (126 MHz, CDCl3): δ 171.8, 154.0, 147.8, 145.3, 135.0, 134.7, 129.9, 129.3, 
128.7, 127.9, 127.6, 124.9, 123.3, 123.1, 122.8, 118.3, 111.4, 48.1, 40.8, 31.4, 28.9, 26.8, 
26.4, 22.5, 21.7, 14.0. HRMS (ESI) m/z Calcd for [C30H31NNaO4S, M+Na]
+
: 524.1866; 
Found: 524.1879.  
Optical Rotation: [α]24D = +5.0 (0.7, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 8.61 
min for major isomer, tR = 33.29 min for minor isomer). 
 
(3S,4S)-3-heptyl-4-phenyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3l). 
Pale yellow viscous oil, 95% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.24 – 8.17 (m, 1H), 8.01 (d, J = 8.4 Hz, 2H), 7.46 – 7.41 (m, 
1H), 7.37 – 7.31 (m, 4H), 7.17 (t, J = 7.5 Hz, 1H), 7.02 (t, J = 7.7 Hz, 
2H), 6.77 (d, J = 6.7 Hz, 2H), 4.21 (d, J = 7.1 Hz, 1H), 2.97 (dd, J = 
14.0, 6.8 Hz, 1H), 2.50 (s, 3H), 1.73 (td, J = 13.8, 7.9 Hz, 2H), 1.24 – 1.16 (m, 10H), 0.85 (d, J 
= 7.0 Hz, 3H).
 13
C NMR (126 MHz, CDCl3): δ 171.8, 154.0, 147.8, 145.3, 135.0, 134.7, 
129.9, 129.3, 128.7, 127.9, 127.6, 124.9, 123.3, 123.1, 122.8, 118.3, 111.4, 48.1, 40.8, 31.6, 
PHD DISSERTATION 2016                                                                   WANG MIN 
118 
29.2, 28.9, 26.8, 26.4, 22.5, 21.7, 14.0. HRMS (ESI) m/z Calcd for [C31H33NNaO4S, M+Na]
+
: 
538.2023; Found: 538.2032. 
Optical Rotation: [α]23D = +2.9 (0.5, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 7.95 
min for major isomer, tR = 31.57 min for minor isomer). 
 
(3S,4S)-3-octyl-4-phenyl-1-tosyl-3,4-dihydrobenzofuro[3,2-b]pyridin-2(1H)-one (3.3m). 
Pale yellow viscous oil, 95% yield, dr > 20:1. 
1
H NMR (500 MHz, 
CDCl3): δ 8.25 – 8.17 (m, 1H), 8.01 (d, J = 8.1 Hz, 2H), 7.46 – 7.40 
(m, 1H), 7.36 – 7.33 (m, 4H), 7.16 (t, J = 7.4 Hz, 1H), 7.02 (t, J = 7.6 
Hz, 2H), 6.77 (d, J = 7.5 Hz, 2H), 4.20 (d, J = 7.0 Hz, 1H), 3.08 – 2.84 
(m, 1H), 2.50 (s, 3H), 1.73 (td, J = 13.7, 7.8 Hz, 2H), 1.19 – 1.09 (m, 12H), 0.86 (d, J = 6.9 Hz, 
3H).
 13
C NMR (126 MHz, CDCl3): δ 171.8, 154.0, 147.9, 145.3, 135.0, 134.8, 129.9, 129.3, 
128.7, 127.9, 127.6, 124.9, 123.3, 123.1, 122.8, 118.3, 111.4, 48.1, 40.8, 31.8, 29.3, 29.2, 
29.1, 26.8, 26.4, 22.6, 21.7, 14.0. HRMS (ESI) m/z Calcd for [C32H35NNaO4S, M+Na]
+
: 
552.2179; Found: 552.2196.  
Optical Rotation: [α]24D = +98.5 (0.5, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 80:20, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 
8.02min for major isomer, tR = 28.47 min for minor isomer). 
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3.4.6 General Procedure for Reduction of cis-Aza-DA 
 
The reduction procedure was according to modified previous reported protocols
103
: To a 
stirred solution of substrates 3.3 (0.1 mmol) in CH2Cl2 (1.0 mL) at 0°C, under N2, was 
dropwise added DIBAL-H (1.0 M in THF, 3.0 ml, 3 mmol). The mixture was stirred at room 
temperature for about 30 min (TLC). When completed, the reaction was quenched with brine 
and extracted with Et2O. The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was purified via SiO2 flash 
chromatography to afford hemiaminal compound. 
To a stirred solution of hemiaminal compound (0.05 mmol) in CH2Cl2 (2.0 mL) at -78°C 
under N2, was added BF3
.
Et2O (19μL, 0.15 mmol) and Et3SiH (17.4 mg, 0.15 mmol). The 
mixture was raised to room temperature and stirred for 2h (TLC). When completed, the 
reaction was quenched with aqueous NaHCO3 solution and extracted with CH2Cl2. The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified via SiO2 flash chromatography to afford product 3.4 as a 
while solid. 
 
3.4.7 Analytical Data of Reduction of cis-Aza-DA Products 
(3S,4S)-3-benzyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.4a). 
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White solid, 66% yield, dr > 20:1. 
1
H NMR (500 MHz, CDCl3): δ 
8.22 (d, J = 7.4 Hz, 1H), 7.30 – 7.14 (m, 9H), 7.11 (d, J = 8.3 Hz, 2H), 
7.04 (d, J = 8.1 Hz, 2H), 6.77 (dd, J = 6.9, 3.4 Hz, 4H), 3.94 (d, J = 6.0 
Hz, 1H), 3.84 (dd, J = 14.7, 3.1 Hz, 1H), 3.34 – 3.17 (m, 1H), 2.43 – 2.38 (m, 1H), 2.36 (s, 3H), 
1.80 – 1.68 (m, 1H), 1.57 (dd, J = 14.0, 10.0 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 154.1, 
147.6, 143.7, 138.6, 137.7, 134.4, 129.8, 129.2, 129.1, 128.5, 128.4, 127.7, 127.5, 126.6, 
124.7, 123.6, 123.0, 123.0, 120.0, 111.2, 47.0, 42.9, 36.4, 36.0, 21.6. HRMS (ESI) m/z Calcd 
for [C31H27NNaO3S, M+Na]
+
: 516.1604; Found: 516.1607. 
Optical Rotation: [α]23D = -35.5 (0.2, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 15.45 




White solid, 62% yield, dr > 20:1. 
1
H NMR (500 MHz, CDCl3): δ 
8.29 (d, J = 7.1 Hz, 1H), 7.37 – 7.27 (m, 6H), 7.21 (dd, J = 8.1, 6.1 
Hz, 4H), 7.13 (d, J = 8.2 Hz, 2H), 6.84 (d, J = 6.8 Hz, 2H), 6.76 (d, J 
= 8.4 Hz, 2H), 3.99 (d, J = 6.0 Hz, 1H), 3.92 (dd, J = 14.7, 3.0 Hz, 
1H), 3.28 (dd, J = 14.6, 12.4 Hz, 1H), 2.44 (s, 3H), 2.41 (dd, J = 14.0, 5.2 Hz, 1H), 1.91 – 1.75 
(m, 1H), 1.70 (dd, J = 14.0, 9.8 Hz, 1H).
 13
C NMR (126 MHz, CDCl3): δ 154.2, 147.0, 143.8, 
138.2, 136.2, 134.4, 133.5, 130.5, 129.8, 129.1, 128.6, 128.6, 127.7, 126.7, 124.9, 123.5, 
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123.1, 123.1, 120.2, 111.2, 47.0, 42.2, 36.3, 35.8, 21.6. HRMS (ESI) m/z Calcd for 
[C31H26ClNNaO3S, M+Na]
+
: 550.1214; Found: 550.1208. 
Optical Rotation: [α]23D = -14.6 (0.2, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 95:5, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 
23.36min for major isomer, tR = 36.10 min for minor isomer). 
 
(3S,4S)-3-heptyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.4c). 
White solid, 68% yield, dr > 20:1. 
1
H NMR (500 MHz, CDCl3): δ 
8.31 (d, J = 7.8 Hz, 1H), 7.55 (d, J = 8.2 Hz, 2H), 7.37 – 7.28 (m, 3H), 
7.25 – 7.18 (m, 5H), 6.82 (dd, J = 6.4, 3.0 Hz, 2H), 3.98 (dd, J = 14.5, 
3.0 Hz, 1H), 3.90 (d, J = 6.0 Hz, 1H), 3.27 (dd, J = 14.4, 12.5 Hz, 1H), 2.43 (s, 3H), 1.56 – 1.46 
(m, 1H), 1.33 – 1.01 (m, 13H), 0.90 (t, J = 7.2 Hz, 3H), 0.53 (ddd, J = 13.9, 8.8, 5.2 Hz, 1H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 147.9, 144.0, 137.9, 134.7, 129.7, 129.1, 128.3, 127.8, 
127.2, 124.6, 123.6, 122.9, 122.9, 119.9, 111.2, 48.0, 42.7, 34.7, 31.8, 29.6, 29.5, 29.2, 27.3, 
22.6, 21.6, 14.1. HRMS (ESI) m/z Calcd for [C31H35NNaO3S, M+Na]
+
: 524.2230; Found: 
524.2223.  
Optical Rotation: [α]23D = -9.7 (0.5, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 95:5, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.00 
min for major isomer, tR = 13.57 min for minor isomer). 
 
(3S,4S)-3-octyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.4d). 
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White solid, 68% yield, dr > 20:1. 
1
H NMR (500 MHz, CDCl3): δ 
8.32 (d, J = 7.8 Hz, 1H), 7.55 (d, J = 8.2 Hz, 2H), 7.37 – 7.27 (m, 3H), 
7.26 – 7.17 (m, 5H), 6.83 (dd, J = 6.4, 2.9 Hz, 2H), 3.99 (dd, J = 14.6, 
3.1 Hz, 1H), 3.90 (d, J = 6.0 Hz, 1H), 3.27 (dd, J = 14.5, 12.5 Hz, 1H), 2.43 (s, 3H), 1.55 – 1.46 
(m, 1H), 1.34 – 1.09 (m, 13H), 0.91 (t, J = 7.1 Hz, 3H), 0.58 – 0.47 (m, 1H). 13C NMR (126 
MHz, CDCl3): δ 154.1, 147.9, 144.0, 137.9, 134.7, 129.7, 129.1, 128.3, 127.8, 127.2, 124.6, 
123.6, 122.9, 122.9, 119.9, 111.2, 48.0, 42.7, 34.7, 31.8, 29.6, 29.5, 29.2, 27.3, 22.7, 21.6, 
14.1. HRMS (ESI) m/z Calcd for [C32H37NNaO3S, M+Na]
+
: 538.2386; Found: 538.2394. 
Optical Rotation: [α]24D = -11.0 (0.4, CHCl3). >99% ee. (HPLC condition: Chiralpak ID 
column, n-hexane/i-PrOH = 95:5, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 
10.38min for major isomer, tR = 12.72 min for minor isomer). 
3.4.8 General Procedure for Chiral Amine Catalyzed 
trans-Aza-DA Reaction 
General procedure. The reaction was carried out with aldehyde 3.5 (0.225 mmol) and 
substrates 3.2 (0.15 mmol) in the presence of catalyst D (0.5 mg, 0.0015 mmol), benzoic acid 
(0.2 mg, 0.0015 mmol) in the mixture of toluene and H2O (1.65 mL, 10:1) at room 
tempareture. After the reaction completed, the mixture was concentrated and the residue was 
purified by flash chromatography on silica gel (hexanes/ethyl acetate = 10:1) to afford the 
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corresponding hemiaminal compound. To an anhydrous dichloromethane solution of the 
hemiaminal compound was added triethyl silane (52.3 mg, 0.45 mmol) and BF3
.
Et2O (56 μL, 
0.45 mmol) in one portion. The reaction mixture was stirred at 0 °C for 5 min and then at 
room temperature until the reaction completed (monitored by TLC). The reaction was 
quenched with aqueous NaHCO3, extracted with CH2Cl2. The organic layer was dried over 
Na2SO4 and concentrated. The crude product was purified by column chromatography 
(hexanes/ethyl acetate = 15:1) to give the final product 3.6 as a while solid. 
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3.4.9 Analytical Data of Chiral Amine Catalyzed trans-Aza-DA 
Reaction Products 
(3R,4S)-3-ethyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.6a). 
Colorless solid, 95% yield, dr = 98:2. 
1
H NMR (500 MHz, CDCl3 ): δ 
8.25 (d, J = 7.8 Hz, 1H), 7.63 (d, J = 8.3 Hz, 2H), 7.31 (q, J = 9.1, 8.0 
Hz, 5H), 7.24 (t, J = 7.2 Hz, 1H), 7.17 (t, J = 7.5 Hz, 2H), 6.56 (d, J = 
7.3 Hz, 2H), 4.44 (dd, J = 14.4, 3.3 Hz, 1H), 3.54 (d, J = 10.0 Hz, 1H), 3.24 (dd, J = 14.5, 
12.0 Hz, 1H), 2.47 (s, 3H), 1.51 – 1.25 (m, 2H), 1.13 – 0.97 (m, 1H), 0.86 (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 149.7, 144.1, 139.4, 134.9, 129.8, 128.3, 128.2, 127.2, 
124.5, 123.9, 123.0, 122.4, 119.3, 111.2, 52.1, 46.6, 40.0, 23.1, 21.5, 11.5. HRMS (ESI) m/z 
Calcd for [C26H26NO3S, M+H]
+
: 432.1633; Found: 432.1622. 
Optical Rotation: [α]25D = +38.2 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.02 




Colorless solid, 84% yield, dr = 98:2. 
1
H NMR (500 MHz, CDCl3 ): 
δ 8.22 (d, J = 7.6 Hz, 1H), 7.60 (d, J = 8.2 Hz, 2H), 7.38 – 7.16 (m, 
7H), 6.42 (d, J = 8.4 Hz, 2H), 4.41 (dd, J = 14.5, 3.2 Hz, 1H), 3.49 
(d, J = 10.1 Hz, 1H), 3.21 (dd, J = 14.5, 12.1 Hz, 1H), 2.46 (s, 3H), 
1.45 – 1.20 (m, 2H), 1.03 (tt, J = 16.1, 7.2 Hz, 1H), 0.84 (t, J = 7.4 Hz, 3H). 13C NMR (126 
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MHz, CDCl3): δ 154.1, 149.0, 144.2, 138.5, 134.8, 131.5, 130.0, 129.8, 128.2, 124.7, 123.8, 
123.2, 122.5, 121.1, 119.5, 111.2, 52.0, 46.0, 39.9, 23.1, 21.6, 11.5. HRMS (ESI) m/z Calcd 
for [C26H25BrNO3S, M+H]
+
: 510.0739; Found: 510.0730. 
Optical Rotation: [α]24D = +15.4 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.00 




Colorless solid, 90% yield, dr = 98:2. 
1
H NMR (500 MHz, CDCl3 ): 
δ 8.22 (d, J = 7.6 Hz, 1H), 7.59 (d, J = 8.3 Hz, 2H), 7.30 (ddd, J = 
17.1, 8.1, 4.1 Hz, 5H), 7.11 (d, J = 8.4 Hz, 2H), 6.46 (d, J = 8.4 Hz, 
2H), 4.40 (dd, J = 14.5, 3.3 Hz, 1H), 3.49 (d, J = 10.1 Hz, 1H), 
3.20 (dd, J = 14.5, 12.1 Hz, 1H), 2.45 (s, 3H), 1.41 – 1.21 (m, 2H), 1.08 – 0.96 (m, 1H), 0.84 
(t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 149.1, 144.2, 138.0, 134.8, 133.0, 
129.8, 129.6, 128.5, 128.2, 124.7, 123.8, 123.1, 122.5, 119.5, 111.2, 52.0, 45.9, 40.0, 23.1, 
21.6, 11.5. HRMS (ESI) m/z Calcd for [C26H25ClNO3S, M+H]
+
: 466.1244; Found: 
466.1241. 
Optical Rotation: [α]23D = +63.8 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.48 
min for major isomer, tR = 20.31 min for minor isomer). 
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(3R,4S)-3-ethyl-4-p-tolyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.6d) 
Colorless solid, 93% yield, dr = 98:2. 
1
H NMR (500 MHz, 
CDCl3 ): δ 8.22 (d, J = 7.8 Hz, 1H), 7.60 (d, J = 8.3 Hz, 2H), 7.36 
– 7.20 (m, 5H), 6.96 (d, J = 7.8 Hz, 2H), 6.43 (d, J = 8.0 Hz, 2H), 
4.41 (dd, J = 14.5, 3.3 Hz, 1H), 3.48 (d, J = 10.1 Hz, 1H), 3.21 (dd, 
J = 14.5, 12.1 Hz, 1H), 2.46 (s, 3H), 2.31 (s, 3H), 1.43 – 1.24 (m, 2H), 1.08 – 0.96 (m, 1H), 
0.83 (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 149.9, 144.1, 136.9, 136.2, 
134.9, 129.8, 129.0, 128.2, 128.2, 124.4, 124.0, 123.0, 122.4, 119.1, 111.2, 52.1, 46.2, 39.9, 
23.1, 21.6, 21.1, 11.5. HRMS (ESI) m/z Calcd for [C27H28NO3S, M+H]
+
: 446.1790; Found: 
446.1785. 
Optical Rotation: [α]26D = +74.7 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.71 




Colorless solid, 92% yield, dr = 99:1. 
1
H NMR (500 MHz, 
CDCl3 ): δ 8.21 (d, J = 7.7 Hz, 1H), 7.60 (d, J = 8.2 Hz, 2H), 7.29 
(ddd, J = 14.5, 9.1, 6.3 Hz, 5H), 6.68 (d, J = 8.7 Hz, 2H), 6.45 (d, 
J = 8.6 Hz, 2H), 4.40 (dd, J = 14.5, 3.2 Hz, 1H), 3.77 (s, 3H), 
3.46 (d, J = 10.1 Hz, 1H), 3.20 (dd, J = 14.4, 12.2 Hz, 1H), 2.45 (s, 3H), 1.45 – 1.20 (m, 2H), 
1.00 (ddd, J = 16.5, 14.1, 7.1 Hz, 1H), 0.83 (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): 
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δ 158.7, 154.0, 150.0, 144.1, 134.9, 131.2, 129.8, 129.2, 128.2, 124.4, 124.0, 123.0, 122.4, 
119.1, 113.7, 111.2, 55.2, 52.2, 45.8, 40.0, 23.1, 21.6, 11.5. HRMS (ESI) m/z Calcd for 
[C27H28NO4S, M+H]
+
: 462.1739; Found: 462.1733. 
Optical Rotation: [α]23D = +96.6 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 14.40 




Colorless solid, 85% yield, dr = 98:2. 
1
H NMR (500 MHz, 
CDCl3 ): δ 8.24 (d, J = 7.6 Hz, 1H), 7.61 (d, J = 8.2 Hz, 2H), 
7.36 – 7.27 (m, 5H), 7.19 (d, J = 8.6 Hz, 1H), 7.13 (t, J = 7.8 Hz, 
1H), 6.65 (d, J = 7.5 Hz, 1H), 6.43 (s, 1H), 4.40 (dd, J = 14.5, 3.2 
Hz, 1H), 3.49 (d, J = 10.2 Hz, 1H), 3.20 (dd, J = 14.5, 12.1 Hz, 1H), 2.44 (s, 3H), 1.41 – 1.31 
(m, 1H), 1.24 – 1.10 (m, 1H), 1.01 (ddq, J = 14.3, 9.6, 7.3 Hz, 1H), 0.84 (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 148.8, 144.5, 141.4, 134.6, 134.4, 130.0, 129.5, 128.0, 
127.6, 127.4, 127.4, 124.7, 123.8, 123.1, 122.6, 119.6, 111.2, 51.9, 46.3, 39.7, 23.0, 21.7, 
11.4. HRMS (ESI) m/z Calcd for [C26H25ClNO3S, M+H]
+
: 466.1244; Found: 466.1229. 
Optical Rotation: [α]24D = +29.0 (0.7, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.34 
min for minor isomer, tR = 20.32 min for major isomer). 
 




Colorless solid, 71% yield, dr = 98:2. 
1
H NMR (500 MHz, CDCl3 ): 
δ 8.23 (d, J = 7.7 Hz, 1H), 7.62 (d, J = 8.2 Hz, 2H), 7.54 (d, J = 7.9 
Hz, 1H), 7.40 – 7.20 (m, 5H), 7.05 (t, J = 7.7 Hz, 1H), 6.89 (t, J = 7.4 
Hz, 1H), 5.85 (d, J = 7.5 Hz, 1H), 4.36 (dd, J = 14.4, 3.0 Hz, 1H), 
4.31 (d, J = 9.6 Hz, 1H), 3.32 (dd, J = 14.4, 11.6 Hz, 1H), 2.45 (s, 3H), 1.53 – 1.32 (m, 2H), 
1.22 – 1.06 (m, 1H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 154.0, 149.0, 
144.1, 139.2, 134.9, 132.9, 129.8, 128.6, 128.2, 127.2, 125.9, 124.6, 123.7, 123.1, 122.4, 
119.5, 111.2, 51.9, 44.6, 40.9, 23.0, 21.6, 11.6. HRMS (ESI) m/z Calcd for [C26H25BrNO3S, 
M+H]
+
: 510.0739; Found: 510.0726. 
Optical Rotation: [α]24D = +51.8 (0.7, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 10.55 




Colorless solid, 95% yield, dr = 96:4. 
1
H NMR (500 MHz, CDCl3 ): 
δ 8.26 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.2 Hz, 2H), 7.37 – 7.23 (m, 
5H), 7.17 (d, J = 7.3 Hz, 1H), 7.11 (t, J = 7.0 Hz, 1H), 6.84 (t, J = 
7.3 Hz, 1H), 5.85 (d, J = 7.6 Hz, 1H), 4.45 (dd, J = 14.4, 3.2 Hz, 
1H), 3.92 (d, J = 10.0 Hz, 1H), 3.30 (dd, J = 14.4, 11.9 Hz, 1H), 2.49 (s, 3H), 2.34 (s, 3H), 
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1.57 – 1.43 (m, 1H), 1.34 (dt, J = 15.1, 7.5 Hz, 1H), 1.16 – 1.02 (m, 1H), 0.88 (t, J = 7.4 Hz, 
3H). 
13
C NMR (126 MHz, CDCl3):δ 154.0, 150.2, 144.1, 137.8, 137.0, 134.9, 130.4, 129.8, 
128.2, 126.9, 126.9, 125.8, 124.4, 123.9, 123.0, 122.3, 119.0, 111.2, 52.1, 41.8, 40.3, 23.2, 
21.6, 19.9, 11.7. HRMS (ESI) m/z Calcd for [C27H28NO3S, M+H]
+
: 446.1790; Found: 
446.1777. 
Optical Rotation: [α]26D = +19.5 (1.0, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 11.69 
min for major isomer, tR = 16.70 min for minor isomer). 
 
(3R,4S)-3-methyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.6i) 
Colorless solid, 97% yield, dr = 98:2. 
1
H NMR (500 MHz, CDCl3 ): δ 
8.24 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 8.3 Hz, 2H), 7.37 – 7.27 (m, 5H), 
7.24 (t, J = 7.4 Hz, 1H), 7.17 (t, J = 7.4 Hz, 2H), 6.55 (d, J = 7.1 Hz, 
2H), 4.29 (dd, J = 14.5, 3.4 Hz, 1H), 3.48 (d, J = 10.0 Hz, 1H), 3.30 (dd, J = 14.5, 12.3 Hz, 
1H), 2.46 (s, 3H), 1.59 – 1.48 (m, 1H), 0.85 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 154.1, 149.6, 144.1, 139.3, 134.9, 129.8, 128.3, 128.1, 128.0, 127.3, 124.6, 123.9, 
123.1, 122.4, 119.4, 111.2, 54.6, 48.2, 34.1, 21.5, 16.1 HRMS (ESI) m/z Calcd for 
[C25H24NO3S, M+H]
+
: 418.1477; Found: 418.1465. 
Optical Rotation: [α]24D = +58.2 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 12.53 
min for major isomer, tR = 24.52 min for minor isomer). 
 




Colorless solid, 93% yield, dr = 99:1. 
1
H NMR (500 MHz, CDCl3 ): 
δ 8.12 (d, J = 7.1 Hz, 1H), 7.31 – 6.98 (m, 13H), 6.76 (d, J = 6.8 Hz, 
2H), 6.55 (d, J = 7.1 Hz, 2H), 4.13 (dd, J = 14.5, 3.3 Hz, 1H), 3.54 
(d, J = 10.2 Hz, 1H), 3.17 (dd, J = 14.5, 12.0 Hz, 1H), 2.61 (dd, J = 13.7, 2.8 Hz, 1H), 2.37 (s, 
3H), 2.05 (dd, J = 13.7, 10.4 Hz, 1H), 1.61 – 1.49 (m, 1H). 13C NMR (126 MHz, CDCl3): δ 
154.1, 149.3, 143.9, 139.0, 138.6, 134.5, 129.7, 129.0, 128.5, 128.5, 128.4, 128.1, 127.5, 
126.7, 124.6, 123.9, 123.0, 122.6, 119.3, 111.2, 51.7, 46.6, 40.8, 36.8, 21.6. HRMS (ESI) 
m/z Calcd for [C31H28NO3S, M+H]
+
: 494.1790; Found: 494.1782. 
Optical Rotation: [α]25D = +33.8 (0.8, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 13.49 
min for major isomer, tR = 29.24 min for minor isomer). 
 
(3R,4S)-3-pentyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.6k) 
Colorless solid, 97% yield, dr = 98:2. 
1
H NMR (500 MHz, 
CDCl3 ): δ 8.14 (d, J = 7.8 Hz, 1H), 7.51 (d, J = 8.3 Hz, 2H), 7.25 
– 7.15 (m, 5H), 7.12 (t, J = 7.3 Hz, 1H), 7.06 (t, J = 7.5 Hz, 2H), 
6.44 (d, J = 7.1 Hz, 2H), 4.31 (dd, J = 14.4, 3.3 Hz, 1H), 3.41 (d, J = 10.1 Hz, 1H), 3.13 (dd, 
J = 14.4, 12.1 Hz, 1H), 2.37 (s, 3H), 1.41 – 1.08 (m, 5H), 1.06 – 0.89 (m, 4H), 0.75 (t, J = 7.3 
Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 149.8, 144.1, 139.4, 134.9, 129.8, 128.3, 
128.3, 128.1, 127.2, 124.5, 123.9, 123.0, 122.4, 119.2, 111.2, 52.6, 46.9, 38.4, 31.7, 30.4, 
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26.6, 22.3, 21.5, 14.0. HRMS (ESI) m/z Calcd for [C29H32NO3S, M+H]
+
: 474.2097; Found: 
474.2110. 
Optical Rotation: [α]26D = +16.7 (1.0, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 9.49 
min for major isomer, tR = 15.87 min for minor isomer). 
 
(3R,4S)-3-isopropyl-4-phenyl-1-tosyl-1,2,3,4-tetrahydrobenzofuro[3,2-b]pyridine (3.6l) 
Colorless solid, 94% yield, dr = 99:1. 
1
H NMR (500 MHz, CDCl3 ): δ 
8.14 (d, J = 7.8 Hz, 1H), 7.52 (d, J = 8.3 Hz, 2H), 7.25 – 7.15 (m, 5H), 
7.12 (t, J = 7.4 Hz, 1H), 7.05 (t, J = 7.4 Hz, 2H), 6.44 (d, J = 7.1 Hz, 
2H), 4.24 (dd, J = 14.4, 3.0 Hz, 1H), 3.70 (d, J = 10.6 Hz, 1H), 3.35 – 3.11 (m, 1H), 2.37 (s, 
3H), 1.49 – 1.41 (m, 1H), 1.36 (ddt, J = 13.5, 10.6, 2.9 Hz, 1H), 0.81 (d, J = 7.0 Hz, 3H), 
0.75 (d, J = 7.1 Hz, 3H). 
13
C NMR (126 MHz, CDCl3): δ 154.1, 150.2, 144.1, 139.6, 135.0, 
129.7, 128.3, 128.2, 128.2, 127.2, 124.5, 123.9, 123.0, 122.4, 119.2, 111.2, 48.7, 43.9, 43.0, 
26.0, 21.6, 21.5, 15.4. HRMS (ESI) m/z Calcd for [C27H28NO3S, M+H]
+
: 446.1790; Found: 
446.1772. 
Optical Rotation: [α]23D = +40.3 (0.9, CHCl3). >99% ee. (HPLC condition: Chiralpak IC 
column, n-hexane/i-PrOH = 90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 9.96 
min for minor isomer, tR = 19.43 min for major isomer). 
 
PHD DISSERTATION 2016                                                                   WANG MIN 
132 
3.4.10. X-ray Crystallographic Analysis and Determination of 
Configuration of the Products 
(1) The absolute configuration of 3.3a (3S, 4S) was assigned by X-ray crystallographic 
analysis of a single crystal of 3.3a (Figure 3-1). The configurations of 3.3b-3.3m and 
3.4a-3.4d were assigned by analogy. 
 
 
Figure 3-1. X-ray structure of 3.3a 
 
Table 3-3. Crystal data and structure refinement for f219 (3.3a) 
 
Identification code  shelx (3.3a) 
Empirical formula  C31H25NO4S 
Formula weight  507.58 
Temperature  100(2) K 
Wavelength  0.71073 Å 
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Crystal system  Monoclinic 
Space group  C 2 
Unit cell dimensions a = 28.6747(15) Å α= 90° 
 b = 9.8103(5) Å β= 100.490(4)° 
 c = 10.2885(6) Å γ = 90° 
Volume 2845.9(3) Å3 
Z 4 
Density (calculated) 1.185 Mg/m3 
Absorption coefficient 0.148 mm-1 
F(000) 1064 
Crystal size 0.594 x 0.428 x 0.238 mm3 
Theta range for data collection 2.683 to 30.554° 
Index ranges -40<=h<=40, -14<=k<=14, -14<=l<=14 
Reflections collected 40477 
Independent reflections 8701 [R(int) = 0.0634] 
Completeness to theta = 25.242° 99.9 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8701 / 1 / 335 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0427, wR2 = 0.1049 
R indices (all data) R1 = 0.0463, wR2 = 0.1068 
Absolute structure parameter 0.08(3)* 
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Largest diff. peak and hole 0.524 and -0.334 e.Å-3 
 
(2) The absolute configuration of 3.6b (3R, 4S) was assigned by X-ray crystallographic 
analysis of a single crystal of 3.6b (Figure 3-2). The configurations of 3.6a, 3.6c-3.3l 
were assigned by analogy. 
 
 
Figure 3-2. X-ray structure of 3.6b 
 
Table 3-4. Sample and crystal data for e449 (3.6b) 
 
Identification code e449 (3.6b) 
Chemical formula C26H24BrNO3S 
Formula weight 510.43 g/mol 
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Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal size 0.380 x 0.470 x 0.530 mm 
Crystal system orthorhombic 
Space group P 21 21 21 
Unit cell dimensions a = 9.6798(5) Å α = 90° 
 
b = 11.2822(6) Å β = 90° 
 
c = 21.2243(12) Å γ = 90° 
Volume 2317.9(2) Å3 
 
Z 4 
Density (calculated) 1.463 g/cm3 
Absorption coefficient 1.892 mm-1 
F(000) 1048 
 
Table 3-5. Data collection and structure refinement for e449 
 
Theta range for data collection 2.31 to 28.33° 
Index ranges -12<=h<=12, -14<=k<=15, -28<=l<=27 
Reflections collected 18489 
Independent reflections 5655 [R(int) = 0.0221] 
PHD DISSERTATION 2016                                                                   WANG MIN 
136 
Max. and min. transmission 0.7457 and 0.6585 
Structure solution technique direct methods 
Structure solution program SHELXS-97 (Sheldrick 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-2014 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 5655 / 0 / 291 
Goodness-of-fit on F2 0.990 
Δ/ζmax 0.001 




R1 = 0.0210, wR2 = 0.0490 
 




Absolute structure parameter 0.0(0) 
Largest diff. peak and hole 0.456 and -0.228 eÅ-3 
R.M.S. deviation from mean 0.049 eÅ-3 
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Chapter 4 Kinetic Resolution of 
1,1'-Spirobiindane-7,7'-Diol via Enantioselective 
Acylation 
4.1 Introduction 
In contrast to biaryls, the spirocyclic framework that contains a quaternary center, is 
considerably more rigid, because the conformational changes involve not merely rotation 
about a single bond, but distortion of the entire molecule.
104
 Thus, it is widely applied as 
chiral catalysts
105
 (Figure 4-1) and ligands 
106
(Figure 4-2) in organic synthesis
107
 and 
sometimes will give better results than biaryls. Notably, all of these chiral catalysts and 
ligands shown in Figure 4-1 and 4-2 are derived from enantiopure 1,1’ -spirobiindane-7, 7’ 
-diol (SPINOL). Efficient enantioselective synthesis of biaryls have been well established in 
recent years by the Tanaka group
108
, the Miller group
109
, the Buchwald group
110
, and many 
others
111
. However, there are limited reports about the preparation of chiral SPINOL in 
enantiopure form. The resolution could serve as one of the possible methods, by forming 
menthol esters
104
, or with cinchonidinium salts
112
, which requires the stoichiometric use of 
chiral compounds.  
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Figure 4-1. Spiro catalysts 
 
 
Figure 4-2. Chiral phosphorus ligands with spiro backbones 
Catalytic kinetic resolution has been developed into a very important method to access 
different chiral alcohols.
113
 In particular, effective preparation of one class of axially chiral 
alcohols including 1,1’-bi-2-naphthol (BINOL) and 2-amino- 2’-hydroxy-1,1’-binaphthyl 
(NOBIN) by catalytic kinetic resolution has been established successfully.
114
 The Tsuji group 
reported a highly enantioselective kinetic resolution of protected BINOLs via asymmetric 
Pd-catalyzed alcoholysis
114c
, while the Maruoka group did kinetic resolution of NOBINs 
through N-alkylation via phase transfer catalysis
114d
 (see a in Scheme 4-1). Recently, my 
group reported the first example of NHC catalyzed acylative kinetic resolution of free 
BINOLs and N-Boc-protected NOBINs to provide them in uniformly 99% ee (see b in 





Scheme 4-1. Catalytic approaches to enantioenriched BINOL and NOBIN. S=selectivity 
factor 
The SPINOL was also investigated in the same paper using the same NHC catalytic system, 
but a low selectivity (s = 3.4) was observed (Scheme 4-2). This may result from the rigid 
structure, which does not allow H bond interaction between its two phenols. 
85h
 
Scheme 4-2. Catalytic kinetic resolution of SPINOL via NHC 
 
In order to improve this initial result of kinetic resolution of SPINOL, I have to investigate 
other conditions or catalytic systems. As mentioned in my group’s reported paper , catalytic 
acylation can be achieved by N-heterocyclic carbene (NHC) catalysis either through simple 
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aldehydes under oxidative conditions or from internal redox reaction of functionalized 
aldehydes (such as α, β-unsaturated aldehydes or α-halo aldehydes).5,7,46,77,83,115 There have 
been several reports of kinetic resolution of secondary alcohols and amines through NHC 
catalyzed acylation.
116
 Following these pioneering work, Catalytic acylation was also 
employed by us for kinetic resolution of oxindole-derived tertiary alcohols successfully.
83
 
NHC-catalyzed high enantioselective acylation of cyclic trans-diols and amino alcohols was 
recently reported by Takasu, Yamada, and coworkers, in which a carboxylate salt could 
enhance the rate and selectivity as a basic cocatalyst.
115f
 
In addition to NHC, a range of other synthetic small molecule catalysts were also developed 
to promote efficient kinetic resolution via catalytic acylation by pioneers such as Fu, Spivey, 
Campbell.
117
 Building on their success, some amidines and isothioureas have been developed 
to promote efﬁcient kinetic resolution by Birman’s group.118 The success of their isothiourea 
catalysts was later expanded by many others for kinetic resolution reactions of 
2-hydroxyalkanoates
119
, 2,2,2-triﬂuoro-1-arylethanols120, and carboxylic acids121. Smith’s 
group subsequently also developed some other structurally related isothiourea catalysts to 
promote the kinetic resolution of a number of simple aryl-alkyl alcohols.
122
  
Recognizing the importance of SPINOL, in this chapter I present here an improved result of 
kinetic resolution of SPINOL via catalytic acylation as a follow-up of my group’s previous 
report.  
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4.2 Results and Discussion 
4.2.1 Optimization of the Kinetic Resolution of SPINOL via NHC 
Catalyzed Acylation 
Following my group’s previous report about kinetic resolution of BINOL, I tried to improve 
the results by screening different aldehydes under NHC catalysis (Scheme 4-3). I repeat the 
reaction by using the same aldehyde 4.2a as used in previous report, and got poor selectivity 
factor of 3.3. Using aldehyde 4.2b combining with MnO2 would go through the same acyl 
azolium intermediate as aldhehyde 4.2a, but the conversion was trace. A nitro group on the 
leaving group of aldehyde 4.2c gave even poor selectivity than aldehyde 4.2a. Then I tested 
some different aldehydes (4.2d and 4.2e) with α position substituted. With increased steric 
hindrance, for aldehydes 4.2d, no reaction occurred, while for aldehyde 4.2e the conversion 
was surprisingly good, but selectivity factor was still very poor. I continued to investigate 
different β substituted enals with either electron withdrawing or donating group on the aryl 
groups (4.2f, 4.2g and 4.2h) under oxidative NHC catalysis, however, I only got the same 
poor selectivity factor. Aldehyde 4.2i that might provide the same intermediate as 4.2f was 
also tested, and gave us very poor selectivity. The selectivity factor was not improved by 
using β-alkyl enals with or without oxidant (4.2j and 4.2k). The same acyl azolium 
intermediate would be generated by using aldehydes (4.2l, 4.2m and 4.2n), however, I still 
cannot get improved selectivity factor than previous report. 
Scheme 4-3. Effect of the aldehyde on the resolution of SPINOL
a 
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[a] The reactions were carried out at ambient temperature with 0.6-0.9 equiv 4.2, 10 mol% 4.4A,1 equiv. DIPEA 
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and with or without 10 equiv. MnO2 in DCM for 20 hours. [b] Determined by HPLC. [c] Determined by 
1H 
NMR analysis of the unpurified reaction mixture. [d] S values were calculated by the methods of Kagan and 
Fiaud
123
: S=ln[(1-Conv.)(1-ee4.1)]/ln[(1-Conv.)(1+ ee4.1)]. 
 
The screening of different NHC precursors was also shown in scheme 4-4. However, no 
significant improvement of the selectivity was obtained (S<4). 
Scheme 4-4. Screening of different NHC catalysts using aldehyde 4.2a 
 
 
Scheme 4-5. Screening of different NHC catalysts using aldehyde 4.2e 
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For oxidative NHC catalysis, I also screened some other NHC catalysts (scheme 4-5). 
Unfortunately, I only got very poor results. 
 
4.2.2 Optimization of the Kinetic Resolution of SPINOL via Other 
Catalyzed Acylation 
Since NHC catalyzed acylation may be not so effective for the resolution of SPINOL, I 
turned my attention to some other catalyzed acylation reactions. I used the readily available 
catalysts 4.5A and 4.5B to catalyze the acylation of SPINOL (entry 1-2, Table 4-1). The 
reactivity was good for both catalysts, but the selectivity was still poor. I chose 
benzotetramisole 4.5B as the catalyst to screen different anhydrides (entry 2-5). To my 
delight, the selectivity was improved by using benzoic anhydride. Later, I found that without 
using catalysts, the reaction can take place just under base condition (entry 6). In order to 
reduce the background reaction, I tried to low the reaction temperature (entry 7-8). When I set 
up the reaction at -20 
o
C, after 22 hours, the conversion was not reduced, but the selectivity 
was improved to 6.5. I continued to screen different solvents for this reaction (entry 8-12). 
DCM was selected as the optimized solvent. Different organic and inorganic bases were also 
tested (entry 13-22). I found that inorganic base K2CO3 gave us better results in terms of 
selectivity factor, which may result from the poor dissolubility in DCM leading to the 
suppressed background reaction. 
Table 4-1. Optimization of kinetic resolution of SPINOL via benzotetramisole
a
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1 4.5A Et 24
0
C DCM DIPEA -6% 68% 1.1 
2 4.5B Et 24
0
C DCM DIPEA 24% 76% 1.4 
3 4.5B i-Pr 24
0
C DCM DIPEA 15% 62% 1.4 
4 4.5B t-Bu 24
0
C DCM DIPEA 5% 33% 1.3 
5 4.5B Ph 24
0
C DCM DIPEA 75% 62% 5.8 
6
e
 - Ph 24
0
C DCM DIPEA 0 38% 1 
7 4.5B Ph -5
0
C DCM DIPEA 79% 63% 6.2 
8 4.5B Ph -20
o
C DCM DIPEA 84% 65% 6.5 
9 4.5B Ph -20
o
C CHCl3 DIPEA 68% 56% 6.5 
10 4.5B Ph -20
o
C THF DIPEA 60% 52% 6.3 
11 4.5B Ph -20
o
C PhMe DIPEA 64% 54% 6.4 
12 4.5B Ph -20
o
C MeCN DIPEA 56% 61% 3.5 
13 4.5B Ph -20
o
C DCM DBU 6% 50% 1.2 
14 4.5B Ph -20
o
C DCM NEt3 71% 60% 5.7 
15 4.5B Ph -20
o
C DCM DMAP 12% 54% 1.4 
16 4.5B Ph -20
o
C DCM DABCO 74% 61% 5.9 
17 4.5B Ph -20
o
C DCM K2CO3 88% 62% 9.2 
PHD DISSERTATION 2016                                                                   WANG MIN 
146 
18 4.5B Ph -20
o
C DCM Na2CO3 76% 56% 8.8 
19 4.5B Ph -20
o
C DCM Li2CO3 31% 33% 5.9 
20 4.5B Ph -20
o
C DCM K3PO4 77% 60% 6.9 
21 4.5B Ph -20
o
C DCM Cs2CO3 56% 63% 3.3 
22 4.5B Ph -20
o
C DCM NaOAc 47% 48% 4.8 
[a] Reaction conditions: 4.1 (0.075 mmol), 4.2 (0.6-0.8 equiv.), 10 mol% of catalyst, 0.8 equiv. of base in 
solvent (0.75 mL) for 22 h, unless noted otherwise. [b] Determined by HPLC. The absolute configuration of the 
recovered 4.1 was assigned by comparison with the same commercial available enantiopure 4.1 on HPLC. [c] 
Determined by 1H NMR analysis of the unpurified reaction mixture. [d] S values were calculated by the 




Until now, I have got improved results of kinetic resolution of SPINOL comparing to my 
group’s previous report. Further optimization of the resolution is still ongoing in my group. 
Later, I will try to expand the substrate scope of this catalytic system. 
4.4 Experimental Section 
4.3.1 General Information 
Thin layer chromatography (TLC) was performed on Merck pre-coated TLC plates (Merck 
60 F254), and compounds were visualized with a UV light at 254nm. Further visualization 
was achieved by potassium permanganate solution followed by heating using a heat gun. 
Flash chromatography separations were performed on Merck 60 (0.040-0.063 mm) mesh 




C NMR spectra were recorded on a Bruker ACF300 (300 MHz) or 
AMX500 (500 MHz) or DPX400 (400 MHz) spectrometer. Chemical shifts were reported in 
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parts per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0) or tetramethylsilane (TMS δ 0.00) 
was used as a reference. Data are reported as follows: chemical shift, multiplicity (s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants (Hz) and 
integration.  High resolution mass spectra (HRMS) were obtained on a Finnigan/MAT 
95XL-T spectrometer. Optical rotations were recorded on an mrc AP81 automatic 
polarimeter.  Enantiomeric excesses (ee) were determined by HPLC analysis on Agilent 
HPLC units, including the following instruments: pump, LC-20AD; detector, SPD-20A; 
column, Chiralpak IA, IB, IC or ID, IF.  
All reactions were carried out under nitrogen atmosphere. All solvents were purified and 
dried according to standard methods prior to use.  
For the kinetic resolution, selectivity factors (S) were calculated according to Kagan’s 
equation
123
: S = ln((1-c)(1-eersm))/ln((1-c)(1+eersm)), wherein c is conversion of the reaction, 
eersm is the enantiomeric excess of the recovered alcohol. Conversions (Conv.) were 
calculated by crude NMR.  
4.3.2 General Procedure 
 
NHC catalysis: To a 4 mL vial was added the racemic SPINOL (0.075 mmol), and triazolium 
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salt 4.4A (0.0075 mmol) (MnO2 (0.75 mmol) was also added if needed in the condition). The 
mixture was taken into the glovebox, where 4Å MS (25 mg), aldehyde (0.052 mmol), 
anhydrous DCM (0.75 mL) and DIPEA (18 μL, 0.075 mmol) were added. The reaction 
mixture was taken outside the glovebox. The vial was then sealed and the reaction mixture 
was allowed to stir at ambient temperature for 20 h. The crude reaction mixture was directly 
filtered and added some interner standard (1,3,5-Trimethoxybenzene) for crude NMR. 
 
 
Benzotetramisole catalysis: To a 4 mL vial was added the racemic SPINOL (19 mg, 0.075 
mmol), benzoic anhydride (10.2 mg, 0.045 mmol) and (+)-Benzotetramisole (1.89 mg, 
0.0075 mmol). The mixture was taken into the glovebox, where K2CO3 (8.3 mg, 0.06 mmol), 
anhydrous DCM (0.75 mL) were added. The reaction mixture was taken outside the glovebox. 
The vial was then sealed and the reaction mixture was allowed to stir at -20
o
C for 22 h. The 
crude reaction mixture was directly filtered and added some internal standard 
(1,3,5-Trimethoxybenzene) for crude NMR. 
 
(S)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol 
Recovered starting material: white solid.
 1
H NMR (500 MHz, CDCl3): δ 7.20 (t, J = 7.7 Hz, 
2H), 6.92 (d, J = 7.4 Hz, 2H), 6.70 (d, J = 8.0 Hz, 2H), 4.69 (br, 2H), 3.12-3.00 (m, 4H), 
2.35-2.31 (m, 2H), 2.26-2.19(m, 2H). 
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88% ee (HPLC condition: Chiralpak ID column, n-hexane/i-PrOH = 
90:10, flow rate = 1.0 ml/min, wavelength = 254 nm, tR = 6.33 min 





H NMR (400 MHz, CDCl3 ): δ 7.50 – 7.38 (m, 3H), 
7.33 (t, J = 7.7 Hz, 1H), 7.26 – 7.22 (m, 3H), 7.15 (d, J = 8.0 Hz, 1H), 
6.96 (t, J = 7.7 Hz, 1H), 6.65 (d, J = 7.5 Hz, 1H), 6.60 (d, J = 8.0 Hz, 
1H), 4.45 (br, 1H), 3.13– 2.94 (m, 3H), 2.83 (dd, J = 15.8, 8.2 Hz, 
1H), 2.36 – 2.25 (m, 3H), 2.23 – 2.11 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 164.7, 152.3, 
147.4, 146.5, 145.0, 138.0, 133.5, 133.0, 129.8, 128.9, 128.8, 128.4, 128.0, 122.7, 121.3, 
117.3, 114.4, 58.5, 38.2, 37.7, 31.2, 31.1. HRMS (ESI) m/z Calcd for [C24H20O3Na, M+Na]
+
: 
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